卵巣・卵管腫瘍病理アトラス　改訂・改題第2版

出版社： 文光堂
著者：
発行日： 2016-10-27
分野： 臨床医学：一般  >  癌/腫瘍一般
ISBN： 9784830604782
電子書籍版： 2016-10-27 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

24,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

24,200 円(税込)

購入する

商品紹介

2004年3月に刊行された「卵巣腫瘍病理アトラス」の改訂版．2014年のWHO分類および2016年の「卵巣腫瘍・卵管癌・腹膜癌取扱い規約（病理編）」をふまえて内容を刷新した．

目次

  • 卵巣・卵管腫瘍病理アトラス　改訂・改題第2版

    ―目次―

    I 総　論
    　1．卵巣腫瘍，卵管腫瘍の組織発生・分類
    　2．卵巣癌の発生・進展に関与する遺伝子
    　3．卵巣腫瘍の画像診断
    　4．卵巣がんの治療
    　5．遺伝性乳癌卵巣癌
    　6．卵巣腫瘍細胞診断の基礎
    　7．卵管上皮内癌と卵巣癌
    　8．卵巣腫瘍の取り扱いと肉眼観察の基礎
    　9．卵巣腫瘍，卵管癌，腹膜癌の臨床的取扱い
    　10．卵巣腫瘍の迅速診断
    　11．免疫組織化学
    　12．卵巣腫瘍とAFP
    　13．小児の卵巣腫瘍
    　14．ヒト卵巣におけるステロイドホルモン産生機構
    　15．機能性間質をもつ卵巣腫瘍
    　16．境界悪性上皮性腫瘍の概念とその播種
    　17．性分化疾患と性腺腫瘍（卵巣腫瘍）
    　18．卵巣癌治療の組織学的治療効果

    II 各　論
    　A．正常卵巣・卵管
    　B．上皮性腫瘍
    　C．間葉系腫瘍
    　D．混合型上皮性間葉系腫瘍
    　E．性索間質性腫瘍
    　F．胚細胞腫瘍
    　G．その他の腫瘍カテゴリー
    　H．腫瘍様病変，その他
    　I．卵管・腹膜の病変
    　1．卵管癌

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 総論

P.13 掲載の参考文献
1) Piek JM, van Diest PJ, Zweemer RP, et al : Tubal ligation and risk of ovarian cancer. Lancet 2001, 358 : 844
PubMed
2) Longrace TA, Wells M : Serous tumours. In : WHO Classification of Tumours of Female Reproductive Organs. (Kurman RJ, Carcangiu ML, Herrington CS. et al. eds.) IARC, Lyon, 2014, 15-16
 
3) 三上芳喜 : 漿液性腫瘍. 腫瘍病理鑑別診断アトラス. (本山悌一, 坂本穆彦編) 文光堂, 東京, 2012, 12-32
 
4) Seidman JD, Cho KR, Ronnett BM, et al : Surface epithelial tumors of the ovary. In : Blaustein's Pathology of the Female Genital Tract. (Kurman RJ, Ellenson LH, Ronnett BM, eds.), 6th edition. Springer Verlag, New York, 2011, 680-784
 
5) Teilum G : Special tumors of ovary and testis. Munksgaad, Copenhagen, 1971
 
6) Nogales FF, Preda O, Nicolae A : Yolk sac tumors revisited. A review of their many faces and names. Histopathology 2012, 60 : 1023-1033
 
7) 中島久良, 塩田充, 西田敬 : 良性の卵巣腫瘍. 新女性医学大系 39 : 産婦人科の良性腫瘍. 中山書店, 東京, 1999, 90-139
 
8) 日本産科婦人科学会婦人科腫瘍委員会第55回治療年報 : 日本産婦人科学会雑誌, 2015, 67 : 1189-1257
 
9) Goldgar D, Strawtton MR, Eeles R, et al : Inherited tumour syndrome. In : WHO Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. (Tavassoli FA, Devilee P, eds.) IARC, Lyon, 2003, 335-363
 
P.15 掲載の参考文献
1) Heatley MK : A systematic review of papers examining the use of intraoperative frozen section in predicting the final diagnosis of ovarian lesions. Int J Gynecol Pathol 2012, 31 : 111-115
 
2) Nochomovitz L, Sidawy M, Silverberg S, et al : Intraoperative Consultation : A Guide to Smears, Imprints, & Frozen Sections. ASCP Press, 1989, 24-41
 
3) Kigawa J, Kaku T, Sugiyama T, et al : Atlas of Clear Cell Carcinoma of the Ovary. A Pathological Guide. Springer Japan, Tokyo, 2015
 
P.20 掲載の参考文献
1) Shih IeM, Kurman RJ : Ovarian tumorigenesis : a proposal model based on morphological and molecular genetic analysis. Am J Pathol 2004, 164 : 1511-1518
 
2) Kurman RJ, Shih IeM : Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer : shifting the paradigm. Hum Pathol 2011, 42 : 918-931
 
3) Clapier CR, Cairns BR : The biology of chromatin remodeling complexes. Annu Rev Biochem 2009, 78 : 273-304
 
4) Oike T, Ogiwara H, Nakano T, et al : Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer. Jpn J Clin Oncol 2013, 43 : 849-855
 
5) Wiegand KC, Shah SP, Al-Agha OM, et al : ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010, 363 : 1532-1543
 
6) Katagiri A, Nakayama K, Rahman MT, et al : Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma. Mod Pathol 2012, 25 : 282-288
 
7) Yamamoto S, Tsuda H, Takano M, et al : PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma. Virchows Arch 2012, 460 : 77-87
 
8) Takenaka M, Saito M, Iwakawa R, et al : Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing. Int J Oncol 2015, 46 : 2389-2398
 
9) Tan DS, Miller RE, Kaye SB : New perspectives on molecular targeted therapy in ovarian clear cell carcinoma. Br J Cancer 2013, 30 : 1553-1559
 
10) Saito M, Okamoto A, Takakura S, et al : Allelic imbalance and mutations of the PTEN gene in ovarian cancer. Int J Cancer 2000, 85 : 160-165
 
11) Gurung A, Hung T, Morin J, et al : Molecular abnormalities in ovarian carcinoma : clinical, morphological and therapeutic correlates. Histopathology 2013, 62 : 59-70
 
12) Enomoto T, Weghorst CM, Inoue M, et al : K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol 1991, 139 : 777-785
 
13) Mok SC, Bell DA, Knapp RC, et al : Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res 1993, 53 : 1489-1492
 
14) Ratner ES, Keane FK, Linder R, et al : A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. Oncogene 2012, 31 : 4559-4566
 
15) Davies H, Bignell GR, Cox C, et al : Mutations of the BRAF gene in human cancer. Nature 2002, 417 : 949-954
 
16) Matsumoto T, Yamazaki M, Takahashi H, et al : Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas. Am J Clin Pathol 2015, 144 : 452-463
 
17) McAlpine JN, Wiegand KC, Vang R, et al : HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy. BMC Cancer 2009, 9 : 433
 
18) Bewtra C, Watson P, Conway T, et al : Hereditary ovarian cancer : a clinicopathological study. Int J Gynecol Pathol 1992, 11 : 180-187
 
19) Ketabi Z, Bartuma K, Bernstein I, et al : Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors. Gynecol Oncol 2011, 121 : 462-465
 
20) Niskakoski A, Kaur S, Renkonen-Sinisalo, et al : Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas. Int J Cancer 2013, 133 : 2596-2608
 
21) DeLeo AB, Jay G, Appella E, et al : Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A 1979, 76 : 2420-2424
 
22) Okamoto A, Sameshima Y, Yokoyama S, et al : Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res 1991, 51 : 5171-5176
 
23) Cancer Genome Atlas Research Network : Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474 : 609-615
 
24) Patch AM, Christie EL, Etemadmoghadam D, et al : Whole-genome characterization of chemoresistant ovarian cancer. Nature 2015, 521 : 489-494
 
25) Mavaddat N, Peock S, Frost D, et al : Cancer risks for BRCA1 and BRCA2 mutation carriers : results from prospective analysis of EMBRACE. J Natl Cancer Inst 2013, 105 : 812-822
 
26) Chen S, Iversen ES, Friebel T, et al : Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 2006, 24 : 863-871
 
27) Bowtell DD : The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer 2010, 10 : 803-808
 
P.30 掲載の参考文献
1) Outwater EK, Dunton CJ : Imaging of the ovary and adnexa : clinical issues and applications of MR imaging. Radiology 1995, 194 : 1-18
 
2) Siegelman ES, Outwater EK : Tissue characterization in the female pelvis by means of MR imaging. Radiology 1999, 212 : 5-18
 
3) Jung SE, Lee JM, Rha SE, et al : CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics 2002, 22 : 1305-1325
 
4) Vargas HA, Barrett T, Sala E : MRI of ovarian masses. J Magn Reson Imaging 2013, 37 : 265-281
 
5) Lai CH, Lin G, Yen TC, et al : Molecular imaging in the management of gynecologic malignancies. Gynecol Oncol 2014, 135 : 156-162
 
6) 田中優美子 : 産婦人科の画像診断. 金原出版, 東京, 2014
 
P.36 掲載の参考文献
1) 日本婦人科腫瘍学会編 : 卵巣がん治療ガイドライン2015年版 (第4版), 金原出版, 東京, 2015
 
2) Vergote I, Trope CG, Amant F, et al : Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 2010, 363 : 943-953
 
3) Katsumata N, Yasuda M, Takahashi F, et al : Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer : a phase 3, open-label, randomised controlled trial. Lancet 2009, 374 : 1331-1338
 
4) Katsumata N, Yasuda M, Isonishi S, et al : Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016) : a randomised, controlled, open-label trial. Lancet Oncol 2013, 14 : 1020-1026
PubMed
5) Armstrong DK, Bundy B, Wenzel L, et al : Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Eng J Med 2006, 354 : 34-43
 
6) Elit L, Oliver TK, Covens A, et al : Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer : a systematic review with metaanalyses. Cancer 2007, 109 : 692-702
 
7) Okamoto A, Sugiyama T, Hamano T, et al : Randomized phase III trial of paclitaxel/carboplatin (PC) versus cisplatin/ irinotecan (CPT-P) as first-line chemotherapy in patients with clear cell carcinoma (CCC) of the ovary : a Japanese Gynecologic Oncology Group (JGOG) /GCIG study. J Clin Oncol 2014, 32 : 5 s (Suppl ; abstr 5507)
 
8) Burger RA, Brady MF, Bookman MA, et al : Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 2011, 365 : 2473-2483
 
9) Perren TJ, Swart AM, Pfisterer J, et al : A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med 2011, 365 : 2484-2496
 
10) Aghajanian C, Blank SV, Goff BA, et al : OCEANS : a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol 2012, 30 : 2039-2045
 
11) Pujade-Lauraine E, Hilpert F, Weber B, et al : Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer : The AURELIA open-label randomized phase III trial. J Clin Oncol 2014, 32 : 1302-1308
 
12) 卵巣腫瘍・卵管癌・腹膜癌取扱い規約 臨床編 (第1版). 金原出版, 東京, 2015
 
13) Ovarian Cancer including Fallopian Tube Cancer and Primary Peritoneal Cancer (Version 2. 2013). NCCN Clinical Practice Guidelines in Oncology
 
14) Gershenson DM : Management of ovarian germ cell tumors. J Clin Oncol 2007, 25 : 2938-2943
 
15) NCI Ovarian Germ Cell Tumors treatment (PDQ(R)) Health Professional Version (09/10/2012))
 
16) Colombo N, Parma G, Zanagnolo V, et al : Management of ovarian stromal cell tumors. J Clin Oncol 2007, 25 : 2944-2951
 
17) Cancer Genome Atlas Research Network : Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474 : 609-615
 
18) Murakami R, Matsumura N, Mandai M, et al : Establishment of a novel histopathological classification of high-grade serous ovarian carcinoma correlated with prognostically distinct gene expression subtypes. Am J Pathol 2016, 186 : 1103-1113
 
19) Gourley C, McCavigan A, Perren T, et al : Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab. J Clin Oncol 2014, 32 : 5s (Suppl ; abstr 5502)
 
20) Winterhoff BJN, Kommoss S, Oberg AL, et al : Bevacizumab and improvement of progression-free survival (PFS) for patients with the mesenchymal molecular subtype of ovarian cancer. J Clin Oncol 2014, 32 : 5s (Suppl ; abstr 5509)
 
P.41 掲載の参考文献
1) Miki Y, Swensen J, Shattuck-Eidens D, et al : A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266 : 66-71
 
2) Wooster R, Bignell G, Lancaster J, et al : Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378 : 789-792
 
3) 日本婦人科腫瘍学会編 : 卵巣がん治療ガイドライン2015年版. 金原出版, 東京, 2015
 
4) Buys SS, Partridge E, Black A, et al : Effect of screening on ovarian cancer mortality. The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA 2011, 305 : 2295-2303
 
5) Rosenthal AN, Fraser L, Manchanda R, et al : Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. J Clin Oncol 2013, 31 : 49-57
 
6) Kauff ND, Domchek SM, Friebel TM, et al : Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer : a multicenter, prospective study. J Clin Oncol 2008, 26 : 1331-1337
 
7) Domchek SM, Friebel TM, Singer CF, et al : Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010, 304 : 967-975
 
8) Pal T, Permuth-Wey J, Betts JA, et al : BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 2005, 104 : 2807-2816
 
9) Tan DS, Rothermundt C, Thomas K, et al : "BRCAness" syndrome in ovarian cancer : a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol 2008, 26 : 5530-5536
 
10) Ledermann J, Harter P, Gourley C, et al : Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer : a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol 2014, 15 : 852-861
 
11) Okamura H, Katabuchi H, Ohba T : What we have learned from isolated cells from human ovary? Mol Cell Endocrinol 2003, 202 : 37-45
 
12) Medeiros F, Muto MG, Lee Y, et al : The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006, 30 : 230-236
 
P.49 掲載の参考文献
1) 日本臨床細胞学会編 :細胞診ガイドライン 1 婦人科・泌尿器2015年版 : 外陰/腟/子宮頸部/子宮体部/卵巣/泌尿器. 金原出版, 東京, 2015, 109-166
 
2) Kurman RJ, Carcangiu LC, Herrington CS, et al. eds : WHO Classification of Tumours of Female Reproductive Organs. 4th edition. IARC, Lyon, 2014
 
3) 日本産科婦人科学会・日本病理学会編 : 卵巣腫瘍・卵管癌・腹膜癌取扱い規約 臨床編. 金原出版, 東京, 2015
 
4) Kigawa J, Kaku T, Sugiyama T, et al : Atlas of Clear Cell Carcinoma of the Ovary : A Pathological Guide. Springer, Heidelberg, 2015
 
P.52 掲載の参考文献
1) Piek JM, van Diest PJ, Zweemer RP, et al : Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001, 195 : 451-456
 
2) Colgan TJ, Murphy J, Cole DE, et al : Occult carcinoma in prophylactic oophorectomy specimens : prevalence and association with BRCA germline mutation status. Am J Surg Pathol 2001, 25 : 1283-1289
 
3) Medeiros F, Muto MG, Lee Y, et al : The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006, 30 : 230-236
 
4) Kindelberger DW, Lee Y, Miron A, et al : Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma : evidence for a causal relationship. Am J Surg Pathol 2007, 31 : 161-169
 
5) Gilks CB, Irving J, Kobel M, et al : Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases : further evidence for the tubal origin of high-grade serous carcinomas. Am J Surg Pathol 2015, 39 : 357-364
 
6) Prat J : Staging classification for cancer of the ovary, fallopian tube, and peritoneum : abridged republication of guidelines from the international federation of gynecology and obstetrics (FIGO). Obstet Gynecol 2015, 126 : 171-174
 
7) Singh N, Gilks CB, Wilkinson N, et al : Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma : a proposal. Histopathology 2014, 65 : 149-154
 
P.57 掲載の参考文献
1) Wenzl R, Lehner R, Husslein P, et al : Laparoscopic surgery in cases of ovarian malignancies : an Austrian-wide survey. Gynecol Oncol 1996, 63 : 57-61
 
2) Piek JM, van Diest PJ, Zweemer RP, et al : Tubal ligation and risk of ovarian cancer. Lancet 2001, 358 : 844
PubMed
3) Seidman JD, Cho KR, Ronnett BM, et al : Surface epithelial tumors of the ovary. In : Blaustein's Pathology of the Female Genital Tract. (Kurman, RJ, Ellenson LH, Ronnett BM, eds.), 6th edition. Springer Verlag, New York, 2011, 847-909
 
4) 前田大地 : 漿液性腺癌. 特集卵巣腫瘍のトピックス. 病理と臨床 2011, 29 : 811-819
 
5) Seidman JD, Kurman RJ, Ronnett BM : Primary and metastatic mucinous adenocarcinomas in the ovaries : incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003, 27 : 985-993
 
6) 清川貴子 : 卵巣腫瘍の病理. 日本産科婦人科学会熊本地方部会雑誌 2009, 53 : 35-39
 
P.62 掲載の参考文献
1) Prat J, FIGO Committee on Gynecologic Oncology : Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 2014, 124 : 1-5
 
2) 日本産科婦人科学会, 日本病理学会編 : 卵巣腫瘍・卵管癌・腹膜癌取扱い規約 臨床編 (第1版). 金原出版, 東京, 2015
 
3) Leslie HS, Christian W編 : TNM 悪性腫瘍の分類 (第7版 日本語版). (UICC日本委員会TNM 委員会訳). 金原出版, 東京, 2010
 
4) UICC : TNM Classification of Malignant Tumours 7th edition. 7th edition TNM and Ovary, Fallopian tube and primary peritoneal carcinoma FIGO 2014. <http://www.uicc.org/sites/main/files/atoms/files/TNM_7_FIGO_OVARY_2014%20FINAL_0.pdf> [Cited 25 Jan 2015]
 
P.67 掲載の参考文献
1) 石黒信吾, 春日井務, 真能正幸,他 : 術中迅速診断の有効性と限界. 病理と臨床 2001, 19 : 10-14
 
2) 中島伸夫 : 卵巣腫瘍の凍結標本. 病理と臨床 1991, 9 : 465-466
 
3) 寺山清美, 向井万起男 : 術中迅速病理診断の精度管理に関する検討. 病理と臨床 2001, 19 : 15-20
 
4) Kushima M : Problems in the pathological diagnosis and intraoperative rapid diagnosis of mucinous tumor of the ovary. Showa Univ J Med Sci 2013, 25 : 1-7
 
5) Stewart CJ, Brennan BA, Koay E, et al : Value of cytology in the intraoperative assessment of ovarian tumors : a review of 402 cases and comparison with frozen section diagnosis. Cancer Cytopathol 2010, 118 : 127-136
 
P.74 掲載の参考文献
1) Dabbs DJ : Immunohistology of the female genital tract. In : Diagnostic Immunohistochemistry, 3rd edition. Saunders, Philadelphia, 2010, 721-742
 
2) Kaspar HG, Crum CP : The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders. Arch Pathol Lab Med 2015, 139 : 39-54
 
3) 前田大地 : 腫瘍の鑑別に用いられる抗体 (各臓器別) -女性生殖器 ; 卵巣. 病理と臨床 臨時増刊号 2014, 32 : 191-200
 
4) Kobel M, Bak J, Bertelsen BI, et al : Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry. Histopathology 2014, 64 : 1004-1013
 
5) Roma AA, Downs-Kelly E : Reliability of PAX8 in clinical practice to accurately determine primary site of origin in female pelvic or abdominal lesions. Ann Diagn Pathol 2014, 18 : 227-231
 
P.80 掲載の参考文献
1) Nogales FF, Bergeron C, Carvia RE, et al : Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases. Am J Surg Pathol 1996, 20 : 1056-1066
 
2) Roth LM, Talerman A, Levy T, et al : Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component. Int J Gynecol Pathol 2011, 30 : 442-451
PubMed
3) Roma AA, Przybycin CG : Yolk sac tumor in postmenopausal patients : pure or associated with adenocarcinoma, a rare phenomenon. Int J Gynecol Pathol 2014, 33 : 477-482
PubMed
4) Miettinen M, Wang Z, McCue PA, et al : SALL4 expression in germ cell and non-germ cell tumors : a systematic immunohistochemical study of 3215 cases. Am J Surg Pathol 2014, 38 : 410-420
 
5) Hanna JH, Saha K, Jaenisch R : Pluripotency and cellular reprogramming : facts, hypotheses, unresolved issues. Cell 2010, 143 : 508-525
 
6) Nogales FF, Preda O, Nicolae A : Yolk sac tumours revisited. A review of their many faces and names. Histopathology 2012, 60 : 1023-1033
 
P.85 掲載の参考文献
1) Norris HJ, Jensen RD : Relative frequency of ovarian neoplasms in children and adolescents. Cancer 1972, 30 : 713-719
 
2) Lack EE, Young RH, Scully RE : Pathology of ovarian neoplasms in childhood and adolescence. Pathol Annu 1992, 27 : 281-356
 
3) Hazard FK, Longacre TA : Ovarian surface epithelial neoplasms in the pediatric population : incidence, histologic subtype, and natural history. Am J Surg Pathol 2013, 37 : 548-553
 
4) Young RH, Scully RE : Ovarian Sertoli-Leydig cell tumors with a retiform pattern : a problem in histopathologic diagnosis. A report of 25 cases. Am J Surg Pathol 1983, 7 : 755-771
 
5) Heravi-Moussavi A, Anglesio MS, Cheng SW, et al : Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 2012, 366 : 234-242
 
6) Witkowski L, Carrot-Zhang J, Albrecht S, et al : Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet 2014, 46 : 438-443
 
P.91 掲載の参考文献
1) Sasano H : Functional pathology of human ovarian steroidogenesis : normal cycling ovary and steroid-producing neoplasms. Endocr Pathol 1994, 5 : 81-89
 
2) Suzuki T, Sasano H, Tamura M, et al : Temporal and spatial localization of steroidogenic enzymes in premenopausal human ovaries : in situ hybridization and immunohistochemical study. Mol Cell Endocrinol 1993, 97 : 135-143
 
3) Sasano H, Suzuki T : Localization of steroidogenesis and steroid recptors in human corpus luteum. Classification of human corpus luteum (CL) into estrogen-producing degenerating CL, and nonsteroid-producing degenerating CL. Semin Reprod Endocrinol 1998, 15 : 345-351
 
4) Takayama K, Sasano H, Fukaya T, et al : Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J Clin Endocrinol Metab 1995, 80 : 2815-2821
 
5) Suzuki T, Sasano H, Kimura N, et al : Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle : relationship to expression of steroidogenic enzymes. Hum Reprod 1994, 9 : 1589-1595
 
6) Takaya R, Fukaya T, Sasano H, et al : Macrophages in normal cycling human ovaries ; immunohistochemical localization and characterization. Hum Reprod 1997, 12 : 1508-1512
 
7) Suzuki T, Sugino N, Fukaya T, et al : Superoxide dismutase in normal cycling human ovaries : immunohistochemical localization and characterization. Fertil Steril 1999, 72 : 720-726
 
8) Tamura M, Sasano H, Suzuki T, et al : Expression of epidermal growth factors and epidermal growth factor receptor in normal cycling human ovaries. Hum Reprod 1995, 10 : 1891-1896
 
9) Reverchon M, Cornuau M, Rame C, et al : Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells. Hum Reprod 2012, 27 : 1790-1800
 
10) Reverchon M, Cornuau M, Cloix L, et al : Visfatin is expressed in human granulosa cells : regulation by metformin through AMPK/SIRT1 pathways and its role in steroidogenesis. Mol Hum Reprod 2013, 19 : 313-326
 
P.96 掲載の参考文献
1) 石倉浩 : 機能性間質をもつ卵巣腫瘍. 卵巣腫瘍病理アトラス (石倉浩, 手島伸一編). 文光堂, 東京, 2004, 330-333
 
2) 石倉浩 : 機能性間質を誘導する卵巣病変の解析. 病理と臨床 1998, 16 : 691-694
 
3) Scully RE, Young RH, Clement PB : Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. In : Atlas of Tumor Pathology 3 rd series, fascicle 23. AFIP, Washington DC, 1998, 373-378
 
4) Kato N, Hayasaka T, Takeda J, et al : Ovarian tumors with functioning stroma : a clinicopathologic study with special reference to serum estrogen level, stromal morphology, and aromatase expression. Int J Gynecol Pathol 2013, 32 : 556-561
 
P.102 掲載の参考文献
1) Kurman RJ, Carcangiu ML, Herrington CS, et al, eds. : WHO Classification of Tumours of Female Reproductive Organs, 4 th edition. IARC, Lyon, 2014, 15-24
 
2) Silverberg SG, Bell DA, Kurman RJ, et al : Borderline ovarian tumors : key points and workshop summary. Hum Pathol 2004, 35 : 910-917.
PubMed
P.109 掲載の参考文献
1) Robby SJ, Mutter GL : Disorders of sexual development. In : Pathology of the Female Reproductive Tract, 3 rd edtion. (Mutter GL, Prat J eds.) Ellsevier, Philadelphia, 2014, 18-47
 
2) MacLaughlin DT, Donahoe PK : Sex determination and differentiation. N Engl J Med 2004, 350 : 367-378
 
3) Hughes IA, Houk C, Ahmed SF, et al : Consensus statement on management of intersex disorders. Arch Dis Child 2006, 91 : 554-563
 
4) 緒方勤, 堀川玲子, 長谷川奉延他 : 性分化異常症の管理に関する合同見解. 日児誌 2008, 112 : 565-578
 
5) Pleskacova J, Hersmus R, Oosterhuis JW, et al : Tumor risk in disorders of sex development. Sex Dev 2010, 4 : 259-269
 
P.115 掲載の参考文献
1) 日本婦人科腫瘍学会編 : 卵巣癌治療ガイドライン2015年版. 金原出版, 東京, 2015
 
2) 固形がんの治療効果判定のための新ガイドライン (RECISTガイドライン) -改訂版version 1.1-日本語訳JCOG版 ver.1.0. 2010
 
3) 日本産科婦人科学会, 日本病理学会編 : 卵巣腫瘍・卵管癌・腹膜癌取扱い規約 臨床編. 金原出版, 東京, 2015
 
4) 日本乳癌学会編 : 臨床・病理 乳癌取扱い規約 第17版. 金原出版, 東京, 2012
 
5) 日本婦人科学会・日本病理学会編 : 卵巣腫瘍・卵巣癌・腹膜癌取扱い規約 病理編 (第1版). 金原出版, 東京, 2016
 
6) Chew I, Soslow RA, Park KJ : Morphologic changes in ovarian carcinoma after neoadjuvant chemotherapy : report of a case showing extensive clear cell changes mimicking clear cell carcinoma. Int J Gynecol Pathol 2009, 28 : 442-446
 
7) Soslow RA, Han G, Park KJ, et al : Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Mod Pathol 2012, 25 : 625-636
 
8) Hafezi-Bakhtiari S, Morava-Protzner I, Burnell MJ, et al : Choriocarcinoma arising in a serous carcinoma of ovary : an example of histopathology driving treatment. J Obstet Gynaecol Can 2010, 32 : 698-702
 
9) Nonaka D, Chiriboga L, Soslow RA : Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 2008, 32 : 1566-1571
 
10) Kindelberger DW, Lee Y, Miron A, et al : Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma : evidence for a causal relationship. Am J Surg Pathol 2007, 31 : 161-169
 
11) 前田大地 : 漿液性腺癌. 特集 : 卵巣腫瘍のトピックス. 病理と臨床 2011, 29 : 811-819
 
12) 長峰理子, 三上芳喜 : 漿液性腫瘍. 特集 : 卵巣腫瘍 I-病理の新しい考えかた-. 病理と臨床 2015, 33 : 938-945
 

II 各論

P.125 掲載の参考文献
1) Mills SE : Histology for Pathologists 4th edition. LWW, Baltimore, 2012
 
2) Sadler TW (安田峯生訳) : ラングマン人体発生学第10版 (原書第11版). メディカル・サイエンス・インターナショナル, 東京, 2010
 
3) Moore KL, Persaud TVN (瀬口春道, 小林俊博, del Saz EG訳) : ムーア人体発生学 (原著第8版). 医歯薬出版, 東京, 2011
 
4) Ross MH, Pawlina W : Histology : A Text and Atlas, with Correlated Cell and Molecular Biology, 6th edition. LWW, Baltimore, 2015
 
5) She ZY, Yang WX : Molecular mechanisms involved in mammalian primary sex determination. J Mol Endocrinol 2014, 53 : R21-R37
 
6) Matzuk MM, Lamb DJ : The biology of infertility : research advances and clinical challenges. Nat Med 2008, 14 : 1197-1213
 
7) Kurman RJ, Shih IeM : The origin and pathogenesis of epithelial ovarian cancer : a proposed unifying theory. Am J Surg Pathol 2010, 34 : 433-443
 
8) Hayashi K, Ogushi S, Kurimoto K, et al : Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice. Science 2012, 338 : 971-975
 
P.127 掲載の参考文献
1) Wharton LR : Two cases of supernumerary ovary and one of accessory ovary, with an analysis of previously reported cases. Am J Obstet Gynecol 1959, 78 : 1101-1119
 
2) Mercer LJ, Toub DB, Cibils LA : Tumors originating in supernumerary ovaries : a report of two cases. J Reprod Med 1987, 32 : 932-934
 
3) Kuga T, Esato K, Takeda K, et al : A supernumerary ovary of the omentum with cystic change : report of two cases and review of the literature. Pathol Int 1999, 49 : 566-570
 
4) Kamiyama K, Moromizato H, Toma T, et al : Two cases of supernumerary ovary : one with large fibroma with Meig's syndrome and the other with endometriosis and cystic change. Pathol Res Pract 2001, 197 : 847-851
 
5) Matsubara Y, Fujioka T, Ikeda T, et al : Periodic size changes in supernumerary ovary with associated corpus luteal cyst. J Obstet Gynecol Res 2009, 35 : 180-182
 
6) Bae HS, Ryu MJ, Kim IS, et al : Cancer of the supernumerary ovary in Mayer-Rokitansky-Kuster-Hauser Syndrome : a case report. Oncol Lett 2013, 5 : 598-600
 
7) Badawy SZ, Kasello DJ, Powers C, et al : Supernumerary ovary with an endometrioma and osseous metaphysia : a case report. Am J Obstet Gynecol 1995, 173 : 1623-1624
 
P.130 掲載の参考文献
1) Silva EG, Deavers MT, Parlow AF, et al : Calcifications in ovary and endometrium and their neoplasms. Mod Pathol 2003, 16 : 219-222
 
2) Vang R, Shih IeM, Kurman RJ : Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology 2013, 62 : 44-58
 
P.136 掲載の参考文献
1) Longacre TA, McKenney JK, Tazelaar HD, et al : Ovarian serous tumors of low malignant potential (borderline tumors) : outcome-based study of 276 patients with long-term (> or=5-year) follow-up. Am J Surg Pathol 2005, 29 : 707-723
PubMed
2) Maniar KP, Wang Y, Visvanathan K, et al : Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/ atypical proliferative serous tumors : a morphologic and immunohistochemical analysis of 37 cases. Am J Surg Pathol 2014, 38 : 743-755
 
3) McKenney JK, Balzer BL, Longacre TA : Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors) : a reevaluation of the concept of stromal microinvasion. Am J Surg Pathol 2006, 30 : 1209-1221
 
4) Djordjevic B, Malpica A : Lymph node involvement in ovarian serous tumors of low malignant potential : a clinicopathologic study of thirty-six cases. Am J Surg Pathol 2010, 34 : 1-9
 
5) Kurman RJ, Vang R, Junge J, et al : Papillary tubal hyperplasia : the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis. Am J Surg Pathol 2011, 35 : 1605-1614
 
6) Laury AR, Ning G, Quick CM, et al : Fallopian tube correlates of ovarian serous borderline tumors. Am J Surg Pathol 2011, 35 : 1759-1765
 
7) May T, Virtanen C, Sharma M, et al : Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary. Gynecol Oncol 2010, 117 : 9-17
PubMed
P.146 掲載の参考文献
1) Soslow RA, Han G, Park KJ, et al : Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Mod Pathol 2012, 25 : 625-636
 
2) Kurman RJ, Shih IeM : Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer : shifting the paradigm. Hum Pathol 2011, 42 : 918-931
 
3) Piek JM, van Diest PJ, Zweemer RP, et al : Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001, 195 : 451-456
 
4) Piek JM, van Diest PJ, Zweemer RP, et al : Tubal ligation and risk of ovarian cancer. Lancet 2001, 358 : 844
PubMed
5) Callahan MJ, Crum CP, Medeiros F, et al : Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 2007, 25 : 3985-3990
 
6) Przybycin CG, Kurman RJ, Ronnett BM, et al : Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 2010, 34 : 1407-1416
 
7) Kuhn E, Meeker A, Wang TL, et al : Shortened telomeres in serous tubal intraepithelial carcinoma : an early event in ovarian high-grade serous carcinogenesis. Am J Surg Pathol 2010, 34 : 829-836
 
8) Salvador S, Rempel A, Soslow RA, et al : Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Gynecol Oncol 2008, 110 : 408-417
 
9) Kobel M, Reuss A, du Bois A, et al : The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas. J Pathol 2010, 222 : 191-198
 
10) May T, Virtanen C, Sharma M, et al : Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary. Gynecol Oncol 2010, 117 : 9-17
PubMed
11) Senturk E, Cohen S, Dottino PR, et al : A critical re-appraisal of BRCA1 methylation studies in ovarian cancer. Gynecol Oncol 2010, 119 : 376-383
 
12) Prat J ; FIGO Committee on Gynecologic Oncology : Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 2014, 124 : 1-5
 
13) Singh N, Gilks CB, Wilkinson N, et al : Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma : a proposal. Histopathology 2014, 65 : 149-154
 
14) Adler E, Mhawech-Fauceglia P, Gayther SA, et al : PAX8 expression in ovarian surface epithelial cells. Hum Pathol 2015, 46 : 948-956
 
15) 武島幸男, 櫛谷桂, Amatya V. Jeet他 : 腹膜悪性中皮腫の病理. 診断病理 2014, 31 : 6-14
 
16) Miettinen M, Wang Z, McCue PA, et al : SALL4 expression in germ cell and non-germ cell tumors : a systematic immunohistochemical study of 3215 cases. Am J Surg Pathol 2014, 38 : 410-420
 
P.147 掲載の参考文献
1) Brustman L, Seltzer V : Sister Joseph's nodule : seven cases of umbilical metastases from gynecologic malignancies. Gynecol Oncol 1984, 19 : 155-162
 
2) 手島伸一, 岸宏久 : 非浸潤性インプラントを繰り返す卵巣漿液性境界悪性腫瘍. 癌診療指針のための病理診断プラクティス婦人科腫瘍 (青笹克文, 本山悌一編). 中山書店, 東京, 2015, 358-363
 
P.148 掲載の参考文献
1) Bell DA : Mucinous adenofibroma of the ovary. A report of 10 cases. Am J Surg Pathol 1991, 15 : 227-232
 
2) Sedman JD, Khedmati F : Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests : a study of 120 tumors. Arch Pathol Lab Med 2008, 132 : 1753-1760
 
3) Cuatrecases M, Villanueva A, Matias-Gulu X, et al : K-ras mutation mucinous ovarian tumors : a clinicopathologic and molecular study of 95 cases. Cancer 1997, 79 : 1581-1586
 
P.152 掲載の参考文献
1) Lee KR, Scully RE : Mucinous tumors of the ovary : a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'. Am J Surg Pathol 2000, 24 : 1447-1464
 
2) Bague S, Rodriguez IM, Prat J : Sarcoma-like mural nodules in mucinous cystic tumors of the ovary revisited : a clinicopathologic analysis of 10 additional cases. Am J Surg Pathol 2002, 26 : 1467-1476
 
3) Vang R, Gown AM, Wu LS, et al : Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary : comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol 2006, 19 : 1421-1428
 
4) Cutatrecases M, Villanueva A, Matias-Guiu X, et al : K-ras mutations in mucinous ovarian tumors : a clinicopathologic and molecular study of 95 cases. Cancer 1997, 79 : 1581-1589
 
P.157 掲載の参考文献
1) Scully RE, Young RH, Clement PB : Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. Atlas of Tumor Pathology. 3rd series, fascicle 23. Armed Forces Institute of Pathology, Washington DC, 1998
 
2) Lee KR, Scully RE : Mucinous tumors of the ovary. A clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinoma, including and evaluation of 11 cases with 'pseudomyxoma peritonei'. Am J Surg Pathol 2000, 24 : 1447-1464
 
3) Kurman RJ, Carcangiu ML, Herrington CS, et al. eds. : WHO Classification of Tumours of Female Reproductive Organs. World Health Organization Classification of Tumours. IARC, Lyon, 2014
 
P.159 掲載の参考文献
1) Prat J, Scully RE : Sarcomas in ovarian mucinous tumors : a report of two cases. Cancer 1979, 44 : 1327-1331
 
2) Bruijin JA, Smit VT, Que DG, et al : Immunohistology of a sarcomatous mural nodule in an ovarian mucinous cystadenocarcinoma. Int J Gynecol Pathol 1987, 6 : 287-293
 
3) Tsujimura T, Kawano K : Rhabdomyosarcoma coexistent with ovarian mucinous cystadenocarcinoma : a case report. Int J Gynecol Pathol 1992, 11 : 58-62
 
P.164 掲載の参考文献
1) Bulun SE : Endometriosis. N Engl J Med 2009, 360 : 268-279
 
2) Stern RC, Dash R, Bentley RC, et al : Malignancy in endometriosis : zfrequency and comparison of ovarian and extraovariantyps. Int J Gynecol Pathol 2001, 20 : 133-139
 
3) Fukunaga M, Nomura K, Ishikawa E, et al : Ovarian atypical endometriosis : its close association with malignant epithelial tumours. Histopathology 1998, 30 : 249-255
 
4) Obata K, Morland SJ, Watson RH, et al : Frequent PTEN/ MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res 1998, 15 : 2095-2097
 
5) Vercellini P, Parazzini F, Bolis G, et al : Endometriosis and ovarian cancer. Am J ObstetGynecol 1993, 169 : 181-182
 
6) Wei JJ, William J, Bulun S : Endometriosis and ovarian cancer : a review of clinical, pathologic, and molecular aspect. Int J Gynecol Pathol 2011, 30 : 553-568
 
7) Maeda D, Shih Iem : Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol 2013, 20 : 45-52
 
8) 福永眞治 : 異型内膜症atypical endometriosisの概念と卵巣明細胞腺癌. 産科と婦人科 2012, 43 : 1233-1237
 
9) Yamamoto S, Tsuda H, Takano M, et al : PIKC3A mutations and low of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma. Virchows Arch 2012, 460 : 77-87
 
10) 小林浩 : 子宮内膜症の悪性化と分子メカニズム. 産婦の実際 2015, 64 : 873-877
 
P.168 掲載の参考文献
1) Bell KA, Kurman RJ : A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differerntiated endometrioid adenocarcinoma of the ovary. Am J Surg Pathol 2000, 24 : 1465-1479
 
2) Kueman RJ, Carcangiu ML, Herrington CS, et al. eds. : WHO Classification of Tumours of Female Reproductive Organs. IARC, Lyon, 2014, 29-32
 
3) 手島伸一, 川端正清 : 卵巣癌の発生母地としての子宮内膜症 : 病理形態学的考察. 日婦人科腫瘍会誌 2003, 21 : 334-338
 
4) 石倉浩, 手島伸一 : 類内膜腫瘍. 病理と臨床 1998, 16 : 723-727
 
5) Uzan C, Berretta R, Rlla M, et al : Management and prognosis of endomerioid borderline tumors of the ovary. Surg Oncol 2012, 21 : 178-184
 
6) 手島伸一, 森谷卓也 : 卵巣腫瘍の新WHO分類. 病理と臨床 2015, 33 : 932-937
 
7) 日本産科婦人科学会, 日本病理学会編 : 卵巣腫瘍・卵管癌・腹膜癌取扱い規約 病理編 (第1版). 金原出版, 東京, 2016
 
8) 加藤哲子 : 子宮内膜症, 境界悪性類内膜腫瘍, 境界悪性明細胞腫瘍の鑑別. 病理と臨床 2015, 33 : 1107-1111
 
P.176 掲載の参考文献
1) 日本産科婦人科学会 : 婦人科腫瘍委員会報告2013年度患者年報. 日産婦誌 2015, 67 : 1872-1916
 
2) Ellenson LH, Carinelli SG, Cho KR, et al : Endometrial tumours. In : WHO Classification of Tumours of Female Reproductive Organs. (Kurman RJ, Carcangiu ML, Herrington CS. et al. eds.) IARC, Lyon, 2014, 29-32
 
3) Ozcan A, Shen SS, Hamilton C, et al : PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors : a comprehensive immunohistochemical study. Mod Pathol 2011, 24 : 751-764
 
4) Madore J, Ren F, Filali-Mouhim A, et al : Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma. J Pathol 2010, 220 : 392-400
 
5) Lim D, Ip PP, Cheung AN, et al : Immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change, and clear cell carcinoma. Am J Surg Pathol 2015, 39 : 1061-1069
 
6) Lerwill MF, Young RH : Metastatic tumors of the ovary. In : Blaustein's Pathology of the Female Genital Tract (Kurman RJ, Lora HE, Brigitte MR eds.), 6 th edition. Springer, New York, 2011, 930-997
 
7) Wani Y, Notohara K, Saegusa M : Aberrant Cdx2 expression in endometrial lesions with squamous differentiation : important role of Cdx2 in squamous morula formation. Hum Pathol 2008, 39 : 1072-1079
 
8) 古屋充子 : 卵巣癌・子宮体癌の重複癌. 特集 : 卵巣腫瘍 II-病理診断の実際. 病理と臨床 2015, 33 : 1117-1121
 
9) 笹島ゆう子 : 類内膜腺癌. 特集 : 卵巣腫瘍 I-病理の新しい考え方. 病理と臨床 2015, 33 : 950-954
 
P.177 掲載の参考文献
1) Itsuno M, Watanabe H, Iwafuchi M, et al : Multiple carcinoids and endocrine cell micronests in type A gastritis : their morphology, histogenesis, and natural history. Cancer 1989, 63 : 881-890
 
2) Abe H, Kubota K, Oka T, et al : A rare case of multiple carcinoids and endocrine cell micronests in a patient with chronic duodenitis. Cancer 2000, 89 : 963-969
 
3) Ishikura H, Shibata M, Yoshiki T : Endocrine cell micronests in an ovarian mucinous cystadenofibroma : a mimic of microinvasion. Int J Gynecol Pathol 1999, 18 : 392-395
 
P.180 掲載の参考文献
1) Gilks CB, Bell DA, Huntsman D, et al : Clear cell tumours. In : WHO Classification of Tumours of Female Reproductive Organs. (Kurman RJ, Carcangiu ML, Herrington CS, et al. eds.) 4th edition. World Health Organization, Geneva, 2014, 33-35
 
2) Yamamoto S, Tsuda H, Yoshikawa T, et al : Clear cell adenocarcinoma associated with clear cell adenofibromatous components : a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics. Am J Surg Pathol 2007, 31 : 999-1006
 
3) Veras E, Mao TL, Ayhan A, et al : Cystic and adenofibromatous clear cell carcinomas of the ovary : distinctive tumors that differ in their pathogenesis and behavior : a clinicopathologic analysis of 122 cases. Am J Surg Pathol 2009, 33 : 844-853
 
4) Yamamoto S, Tsuda H, Takano M, et al : Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary : a possible alternative ovarian clear-cell carcinogenic pathway. J Pathol 2008, 216 : 103-110
PubMed
5) Zhao C, Wu LS, Barner R : Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma : clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer 2011, 2 : 94-106
 
P.188 掲載の参考文献
1) Anglesio MS, Carey MS, Kobel M, et al : Clear cell carcinoma of the ovary : a report from the first Ovarian Clear Cell Symposium, June 24th, 2010. Gynecol Oncol 2011, 121 : 407-415
 
2) Mizuno M, Kikkawa F, Shibata K, et al : Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary. J Surg Oncol 2006, 94 : 138-143
 
3) Takano M, Kikuchi Y, Yaegashi N, et al : Clear cell carcinoma of the ovary : a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer 2006, 94 : 1369-1374
 
4) Tan DS, Kaye S : Ovarian clear cell adenocarcinoma : a continuing enigma. J Clin Pathol 2007, 60 : 355-360
 
5) Veras E, Mao TL, Ayhan A, et al : Cystic and adenofibromatous clear cell carcinomas of the ovary : distinctive tumors that differ in their pathogenesis and behavior : a clinicopathologic analysis of 122 cases. Am J Surg Pathol 2009, 33 : 844-853
 
6) Yamashita Y, Nagasaka T, Naiki-Ito A, et al : Napsin A is a specific marker for ovarian clear cell adenocarcinoma. Mod Pathol 2015, 28 : 111-117
 
7) Yamamoto S, Tsuda H, Takano M, et al : Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary : a possible alternative ovarian clear-cell carcinogenic pathway. J Pathol 2008, 216 : 103-110
PubMed
8) Yamaguchi K, Mandai M, Oura T, et al : Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes. Oncogene 2010, 29 : 1741-1752
 
9) Yamashita Y : Ovarian cancer : new developments in clear cell carcinoma and hopes for targeted therapy. Jpn J Clin Oncol 2015, 45 : 405-407.
PubMed
10) Yamamoto S, Tsuda H, Takano M, et al : Loss of ARID1 A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations. Mod Pathol 2012, 25 : 615-624
 
P.192 掲載の参考文献
1) Kurman RJ, Carcangiu ML, Herrington CS, et al. eds. : WHO Classification of Tumours of Female Reproductive Organs. 4th edition. IARC, Lyon, 2014, 35-36
 
2) 奥平吉雄, 松井義明, 沢田益臣他 : Brenner腫瘍の微細構造とhistogenesisに関する問題点. 産婦の実際1984, 33 : 941-953
 
3) Klemi PJ, Nevalainen TJ : Ultrastructure of the benign and borderline Brenner tumours. Acta Pathol Microbiol Scand [A] 1977, 85 : 826-838
 
4) 九島巳樹, 鬼塚淑子, 石田憲毅他 : 悪性ブレンナー腫瘍の1例および文献的考察. 病理と臨床 1994, 12 : 367-373
 
5) Ruggiero S, Ripetti V, Bianchi A, et al : A singular observation of a giant benign Brenner tumor of ovary. Arch Gynecol Obstet 2011, 284 : 513-516
 
6) Baker PM, Young RH : Brenner tumor of the ovary with striking microcystic change. Int J Gynecol Pathol 2003, 22 : 185-188
 
7) 澤田まどか, 九島巳樹, 外池孝彦他 : 卵巣Brenner腫瘍の免疫組織化学的検討. 診断病理 2005, 22 : 13-20
 
P.194 掲載の参考文献
1) Woodruff JD, Dietrich D, Genadry R, et al : Proliferative and malignant Brenner tumors. Review of 47 cases. Am J Obstet Gynecol 1981, 141 : 118-125
 
2) Uzan C, Dufeu-Lefebvre M, Fauvet R, et al : Management and prognosis of borderline ovarian Brenner tumors. Int J Gynecol Cancer 2012, 22 : 1332-1336
 
3) Kuhn E, Ayhan A, Shih IeM, et al : The pathogenesis of atypical proliferative Brenner tumor : an immunohistochemical and molecular genetic analysis. Mod Pathol 2014, 27 : 231-237
 
P.198 掲載の参考文献
1) Austin RM, Norris HJ : Malignant Brenner tumor and transitional cell carcinoma of the ovary : a comparison. Int J Gynecol Pathol 1987, 6 : 29-39
 
2) Cuatrecasas M, Catasus L, Palacios J, et al : Transitional cell tumors of the ovary : a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. Am J Surg Pathol 2009, 33 : 556-567
 
3) Ali RH, Seidman JD, Luk M, et al : Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2012, 31 : 499-506
 
4) Takeuchi T, Ohishi Y, Imamura H, et al : Ovarian transitional cell carcinoma represents a poorly differentiated form of high-grade serous or endometrioid adenocarcinoma. Am J Surg Pathol 2013, 37 : 1091-1099
PubMed
5) Soslow RA, Han G, Park KJ, et al : Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Mod Pathol 2012, 25 : 625-636
 
P.204 掲載の参考文献
1) Rutgers JL, Scully RE : Ovarian Mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer 1988, 61 : 340-348
 
2) Rutgers JL, Scully RE : Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of Mullerian type. A clinicopathologic analysis. Cancer 1988, 61 : 546-554
 
3) Bostwick DG, Tazelaar HD, Ballon SC, et al : Ovarian epithelial tumors of borderline malignancy. A clinicopathological study of 109 cases. Cancer 1986, 58 : 2052-2065
 
4) Silverberg SG, Bell DA, Kurman RJ, et al : Borderline ovarian tumors : key points and workshop summary. Hum Pathol 2004, 35 : 910-917
 
5) Hart WR : Mucinous tumors of the ovary : A review. Int J Gynecol Pathol 2005, 24 : 4-25.
PubMed
6) Shappell HW, Riopel MA, Smith Sehdev AE, et al : Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors : atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol 2002, 26 : 1529-1541
 
7) Rodriguerz IM, Irving JA, Prat J : Endocervical-like mucinous borderline tumors of the ovary : a clinicopathologic analysis of 31 cases. Am J Surg Pathol 2004, 28 : 1311-1318
 
8) Lee KR, Nucci MR : Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type : a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis. Int J Gynecol Pathol 2003, 22 : 42-51
 
9) Dube V, Roy M, Plante M, et al : Mucinous ovarian tumors of Mullerian-type : an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas. Int J Gynecol Pathol 2005, 24 : 138-146
 
10) Taylor J, McCluggage WG : Ovarian seromucinous carcinoma : report of a series of a newly categorized and uncommon neoplasm. Am J Surg Pathol 2015, 39 : 983-992
 
11) Hamada T, Kiyokawa T, Nomura K, et al : Immunohistochemical analysis of reserve cell-like cells of ovarian mullerian mucinous/mixed epithelial borderline tumor. Int J Gynecol Pathol 2008, 27 : 199-206
 
12) Maeda D, Shih IeM : Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol 2013, 20 : 45-52
 
13) Wu CH, Mao TL, Vang R, et al : Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int J Gynecol Pathol 2012, 31 : 297-303
 
P.206 掲載の参考文献
1) Nagai Y, Kishimoto T, Nikaido T, et al : Squamous predominance in mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type arising in endometriotic cysts : a study of four cases. Am J Surg Pathol 2003, 27 : 242-247
 
P.209 掲載の参考文献
1) Silva EG, Tornos C, Baily MA, et al : Undifferentiated carcinoma of the ovary. Arch Pathol Lab Med 1991, 115 : 377-381
 
2) Oliva E, Andrada E, Pezzica E, et al : Ovarian carcinomas with choriocarcinomatous differentiation. Cancer 1993, 72 : 2441-2446
 
3) Kuwashima Y, Uehara T, Kishi K, et al : Immunohistochemical characterization of undifferentiated carcinomas of the ovary. J Cancer Res Clin Oncol 1994, 120 : 672-677
 
4) Eichhorn JH, Laurence WD, Young RH, et al : Ovarian neuroendocrine carcinomas of non-small-cell type associated with surface epithelial adenocarcinomas. A study of five cases with review of the literature. Int J Gynecol Pathol 1996, 15 : 303-314
 
5) Tafe LJ, Garg K, Chew I, et al : Endometrial and ovarian carcinomas with undifferentiated components : clinically aggressive and frequently underrecognized neoplasms. Mod Pathol 2010, 23 : 781-789
 
P.210 掲載の参考文献
1) Yetman TJ, Dudzinski MR : Primary squamous carcinoma of the ovary : a case report and review of the literature. Gynecol Oncol 1989, 34 : 240-243
 
2) Pins MR, Young RH, Daly WJ, Scully RE : Primary squamous cell carcinoma of the ovary. Report of 37 cases. Am J Surg Pathol 1996, 20 : 823-833
 
3) Park JY, Song JS, Choi G, : Pure primary squamous cell carcinoma of the ovary : a reoprt of two cases and review of the literature. Int J Gynecol Pathol 2010, 29 : 328-334
 
P.213 掲載の参考文献
1) Khunamornpong S, Suprasert P, Chiangmai WN, et al : Metastatic tumors to the ovaries : a study of 170 cases in northern Thailand. Int J Gynecol Cancer 2006, 16 (Suppl 1) : 132-138
 
2) Yada-Hashimoto N, Yamamoto T, Kamiura S, et al : Metastatic ovarian tumors : a review of 64 cases. Gynecol Oncol 2003, 89 : 314-317
 
3) Vang R, Cheung ANY, Kommoss F, et al : Secondary Tumours. In : WHO Classification of Tumours of the Female Reproductive Organs. (Kurman RJ, Carcangiu ML, Herrington CS, et al. eds.), 4th edition. IARC, Lyon, 2014, 83-86
 
4) Kigawa J, Kaku T, Sugiyama T, et al : Atlas of Clear Cell Carcinoma of the Ovary. Springer Japan, 2015
 
5) Stern RC, Dash R, Bentley RC, et al : Malignancy in endometriosis : frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol 2001, 20 : 133-139
 
6) Cuatrecasas M, Catasus L, Palacios J, et al : Transitional cell tumors of the ovary : a comparative clinicopathological, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. Am J Surg Pathol 2009, 33 : 556-567
 
7) Shappell HW, Riopel MA, Smith Sehdev AE, et al : Diagnostic criteria and behavior of ovarian seromucinous (endocervical -type mucinous and mixed cell-type) tumors : atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol 2002, 26 : 1529-1541
 
P.216 掲載の参考文献
1) Young RH, Prat J, Scully RE : Endometrioid stromal sarcomas of the ovary. A clinicopathologic analysis of 23 cases. Cancer 1984, 53 : 1143-1155
 
2) Oliva E, Egger JF, Young RH : Primary endometrioid stromal sarcoma of the ovary : a clinicopathologic study of 27 cases with morphologic and behavioral features similar to those of uterine low-grade endometrial stromal sarcoma. Am J Surg Pathol 2014, 38 : 305-315
 
3) Chang KL, Crabtree GS, Lim-Tan SK, et al : Primary extrauterine endometrial stromal neoplasms : a clinicopathologic study of 20 cases and a review of the literature. Int J Gynecol Pathol 1993, 12 : 282-296
 
4) Masand RP, Euscher ED, Deavers MT, et al : Endometrioid stromal sarcoma : a clinicopathologic study of 63 cases. Am J Surg Pathol 2013, 37 : 1635-1647
 
5) Ellenson LH, Carinelli SG, Cho KR, et al : Mesenchymal tumours. In : WHO Classification of Tumours of Female Reproductive Organs (Kurman RJ, Carcangiu ML, Herrington CS, et al. eds.), 4th edition. IARC, Lyon, 2014, 41
 
P.219 掲載の参考文献
1) Eichhorn JH, Young RH, Clement PB, et al : Mesodermal (Mullerian) adenosarcoma of the ovary : a clinicopathologic analysis of 40 cases and a review of the literature. Am J Surg Pathol 2002, 26 : 1243-1258
 
2) Gallardo A, Prat J : Mullerian adenosarcoma : a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol 2009, 33 : 278-288
 
3) Howitt BE, Sholl LM, Dal Cin P, et al : Targeted genomic analysis of Mullerian adenosarcoma. J Pathol 2015, 235 : 37-49
 
4) Piscuoglio S, Burke KA, Ng CK, et al. Uterine adenosarcomas are mesenchymal neopasms. J Pathol 2016, 238 : 381-388
 
5) Lee JC, Lu TP, Changou CA, et al : Genomewide copy number analysis of Mullerian adenosarcoma identified chromosomal instabiliry in the aggressive subgroup. Modern Pathology 2016, 29 : 1070-1082
 
P.222 掲載の参考文献
1) Fujii H, Yoshida M, Gong ZX, et al : Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Res 2000, 60 : 114-120
 
2) Berton-Rigaud D, Devouassoux-Shisheboran M, Ledermann JA, et al : Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma. Int J Gynecol Cancer 2014, 24 : S55-S60
 
P.224 掲載の参考文献
1) Ehrmann RL, Weidner N, Welch WR, et al : Malignant mixed mullerian tumor of the ovary with prominent neuroectodermal differentiation (teratoid carcinosarcoma). Int J Gynecol Pathol 1990, 9 : 272-282
 
2) Tanimoto A, Arima N, Hayashi R, et al : Teratoid carcinosarcoma of the ovary with prominent neuroectodermal differentiation. Pathol Int 2001, 51 : 829-832
 
3) Ohishi Y, Kaku T, Kaneki E, et al : Malignant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac tumor and immature teratoma with prominent neuroectodermal and rhabdomyosarcomatous differentiation : a case study. Gynecol Oncol 2007, 105 : 548-552
 
4) Garcia-Galvis OF, Cabrera-Ozoria C, Fernandez JA, et al : Malignant mullerian mixed tumor of the ovary associated with yolk sac tumor, neuroepithelial and trophoblastic differentiation (teratoid carcinosarcoma). Int J Gynecol Pathol 2008, 27 : 515-520
 
5) Matsuura Y, Kitajima M, Hachisuga T, et al : Malignant mixed mullerian tumor with malignant neuroectodermal components (teratoid carcinosarcoma) of the ovary : report of a case with clinicopathologic findings. J Obstet Gynaecol Res 2010, 36 : 907-911
 
P.227 掲載の参考文献
1) 清川貴子 : 性索間質性腫瘍. 特集 : 卵巣腫瘍 I-病理の新しい考え方. 病理と臨床2015, 33 : 970-976
 
2) Irving JA, Alkushi A, Young RH, et al : Cellular fibromas of the ovary : a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma. Am J Surg Pathol 2006, 30 : 929-938
 
3) Meigs JV, Cass JW : Fibroma of the ovary with ascites and hydrothorax. Am J Obstet Gynecol 1937, 33 : 249-267
 
4) Meigs JV : Fibroma of the ovary with ascites and hydrothorax ; Meigs' syndrome. Am J Obstet Gynecol 1954, 67 : 962-985
 
5) Gorlin RJ : Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 1987, 66 : 98-113
 
6) Hahn H, Wicking C, Zaphiropoulous PG, et al : Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996, 85 : 841-851
 
P.231 掲載の参考文献
1) McCluggage WG, Staats PN, Kiyokawa T, et al : Sex cord-stromal tumours- pure stromal tumours. In : WHO Classification of Tumours of Female Reproductive Organs. IARC, Lyon, 2014, 45
 
2) Young H : Sex-cord stromal, Steroid cell, and Other Ovarian Tumors with Endocrine, Paraendocrine, and Paraneoplastic Manifestations. In : Blaunstein's Pathology of the Female Genital Tract. 6th edition. Springer, 2011, 805-806
 
3) Burandt E, Young RH : Thecoma of the ovary : a report of 70 cases emphasizing aspects of its histopathology different from those often portrayed and its differential diagnosis. Am J Surg Pathol 2014, 1023-1032
 
P.235 掲載の参考文献
1) Clement PB, Young RH, Hanna W, et al : Sclerosing peritonitis associated with luteinized thecomas of the ovary. A clinicopathological analysis of six cases. Am J Surg Pathol 1994, 18 : 1-13
PubMed
2) Staats PN, McCluggage WG, Clement PB, et al : Luteinized thecomas (thecomatosis) of the type typically associated with sclerosing peritonitis : a clinical, histopathologic, and immunohistochemical analysis of 27 cases. Am J Surg Pathol 2008, 32 : 1273-1290
 
P.238 掲載の参考文献
1) Prat J, Scully RE : Cellular fibromas and fibrosarcomas of the ovary : a comparative clinicopathologic analysis of seventeen cases. Cancer 1981, 47 : 2663-2670
 
2) Irving JA, Alkushi A, Young RH, et al : Cellular fibromas of the ovary : a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma. Am J Surg Pathol 2006, 30 : 929-938
 
3) Lee H-Y, Ahmed Q : Fibrosarcoma of the ovary arising in a fibrothecomatous tumor with minor sex cord elements : a case report and review of the literature. Arch Pathol Lab Med 2003, 127 : 81-84
 
P.243 掲載の参考文献
1) McCluggage WG, Staats PN, Kiyokawa T, et al : Sclerosing stromal tumor. Sex cord-stromal tumours-pure stromal tumours. In : WHO Classification of Tumours of Female Reproductive Organs (Kurman RJ, Carcangiu ML, Herrington CS, et al. eds.), 4th edition. IARC, Lyon, 2014, 46-47
 
2) Chalvardjian A, Scully RE : Sclerosing stromal tumors of the ovary. Cancer 1973, 31 : 664-670
 
3) Scully RE, Young RH, Clement PB. eds. : Stromal tumors. Atras of Tumor Pathology : Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. 3rd series. AFIP, Washington D.C., 1999, 189-202
 
4) Shaw JA, Dabbs DJ, Geisinger KR : Sclerosing stromal tumor of the ovary : an ultrastructural and immunohistochemical analysis with histogenetic considerations. Ultrastruct Pathol 1992, 16 : 363-377
 
5) Jung NH, Kim T, Kim HJ, et al : Ovarian sclerosing stromal tumor presenting as Meigs' syndrome with elevated CA-125. J Obstet Gynaecol Res 2006, 32 : 619-622
 
6) Saitoh A, Tsutsumi Y, Osamura RY, et al : Sclerosing stromal tumor of the ovary. Immunohistochemical and electron-microscopic demonstration of smooth-muscle differentiation. Arch Pathol Lab Med 1989, 113 : 372-376
 
7) Lam RM, Geittmann P : Sclerosing stromal tumor of the ovary : a light, electronmicroscopic and enzyme histochemical study. Int J Gynecol Pathol 1998, 7 : 280-290
 
8) Boussaid K, Meduri G, Maiza JC, et al : Virilizing sclerosing-stromal tumor of the ovary in a young woman with McCune Albright syndrome : clinical, pathological, and immunohistochemical studies. J Clin Endocrinol Metab 2013, 98 : E314-E320
 
9) Kawauchi S, Tsuji T, Kaku T, et al : Sclerosing stromal tumor of the ovary : a clinicopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis with special reference to its vasculature. Am J Surg Pathol 1998, 22 : 83-92
 
10) Scully RE, Young RH, Clement PB. eds. : Secondary (including hematopietic) tumors. Atras of Tumor Pathology : Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. 3 rd series. AFIP, Washington D.C., 1999, 335-372
 
11) Meigs JV : Fibroma of the ovary with ascites and hydrothorax ; Meigs' syndrome. Am J Obstet Gynecol 1954, 67 : 962-985
 
P.246 掲載の参考文献
1) Ramzy I : Signet-ring stromal tumor of ovary. Histochemical, light, and electron microscopic study. Cancer 1976, 38 : 166-172
 
2) Suarez A, Palacios J, Burgos E, et al : Signet-ring stromal tumor of the ovary : a histochemical, immunohistochemical and ultrastructural study. Virchows Arch A Pathol Anat Histopathol 1993, 422 : 333-336
 
3) Dickersin GR, Young RH, Scully RE : Signet-ring stromal and related tumors of the ovary. Ultrastruct Pathol 1995, 19 : 401-419
 
4) Cashell AW, Jerome WG, Flores E : Signet ring stromal tumor of the ovary occurring in conjunction with brenner tumor. Gynecol Oncol 2000, 77 : 323-326
 
5) Su RM, Chang KC, Chou CY : Signet-ring stromal tumor of the ovary : a case report. Int J Gynecol Cancer 2003, 13 : 90-93
 
6) Vang R, Bague S, Tavassoli FA, et al : Signet-ring stromal tumor of the ovary : clinicopathologic analysis and comparison with Krukenberg tumor. Int J Gynecol Pathol 2004, 23 : 45-51
 
7) Matsumoto M, Hayashi Y, Ohtsuki Y, et al : Signet-ring stromal tumor of the ovary : an immunohistochemical and ultrastructural study with a review of the literature. Med Mol Morphol 2008, 41 : 165-170
 
8) Hardisson D, Regojo RM, Marino-Enriquez A, et al : Signet-ring stromal tumor of the ovary : report of a case and review of the literature. Pathol Oncol Res 2008, 14 : 333-336
 
9) Forde GK, Harrison C, Doss BJ, et al : Bilateral and multinodular signet-ring stromal tumor of the ovary. Obstet Gynecol 2010, 116 Suppl 2 : 556-558
 
10) Sukur YE, Ozmen B, Atabeko'lu CS, et al : Signet-ring stromal tumor of the ovary : an extremely rare neoplasm. J Turk Ger Gynecol Assoc 2011, 12 : 59-60
 
P.249 掲載の参考文献
1) Irving JA, Young RH : Microcystic stromal tumor of the ovary : report of 16 cases of a hitherto uncharacterized distinctive ovarian neoplasm. Am J Surg Pathol 2009, 33 : 367-375
 
2) Maeda D, Shibahara J, Sakuma T, et al : β-catenin (CTNNB1) S33C mutation in ovarian microcystic stromal tumors. Am J Surg Pathol 2011, 35 : 1429-1440
 
3) 越浩美, 佐野孝昭, 瀬川篤記他 : Gardner症候群に発生したmicrocystic stromal tumor of the ovaryの1例. 診断病理 2013, 30 : 53-57
 
4) Irving JA, Lee CH, Yip S, et al : Microcystic Stromal Tumor : a distinctive ovarian sex cord-stromal neoplasm characterized by FOXL2, SF-1, WT-1, Cyclin D1, and β-catenin nuclear expression and CTNNB1 mutations. Am J Surg Pathol 2015, 39 : 1420-1426
 
5) Lee SH, Koh YW, Roh HJ, et al : Ovarian microcystic stromal tumor : a novel extracolonic tumor in familial adenomatous polyposis. Genes Chromosomes Cancer 2015, 54 : 353-360
 
6) Deshpande V, Oliva E, Young RH : Solid pseudopapillary neoplasm of the ovary : a report of 3 primary ovarian tumors resembling those of the pancreas. Am J Surg Pathol 2010, 34 : 1514-1520
 
P.250 掲載の参考文献
1) Teilum G : Special Tumors of Ovary and Testis. Comparative Pathology and Histological Identification. 2nd edition. Lippincott, Philadelphia, 1976, 135-136, 244-245
 
2) Yamada Y, Ohmi K, Tsunematu R, et al : Gynandroblastoma of the ovary having a typical morphological appearance : a case study. Jpn J Clin Oncol 1991, 21 : 62-68
 
P.255 掲載の参考文献
1) Sun HD, Lin H, Jao MH, et al : A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. Gynecol Oncol 2012, 124 : 244-249
 
2) Deavers MT, Malpica A, Liu J, et al : Ovarian sex cord-stromal tumors : an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol 2003, 16 : 584-590
 
3) Al-Agha OM, Huwait HF, Chow C, et al : FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 2011, 35 : 484-494
 
P.259 掲載の参考文献
1) Young RH, Dickersin GR, Scully RE : Juvenile granulose cell tumor of the ovary. A clinicopathologic analysis of 125 cases. Am J Surg Pathol 1984, 8 : 575-596
 
2) Irving JA, Young RH : Granulosa cell tumors of the ovary with a pseudopapillary pattern : a study of 14 cases of an unusual morphologic variant emphasizing their distinction from transitional cell neoplasms and other papillary ovarian tumors. Am J Surg Pathol 2008, 32 : 581-586
 
3) Al-Agha OM, Huwait HF, Chow C, et al : FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 2011, 35 : 484-494
 
4) Gell JS, Stannard MW, Ramnani DM, et al : Juvenile granulosa cell tumor in a 13-year-old girl with enchondromatosis (Ollier's disease) : a case report. J Pediatr Adolesc Gynecol 1998, 11 : 147-150
 
5) Tanaka Y, Sasaki Y, Nishihara H, et al : Ovarian juvenile granulose cell tumor associated with Maffucci's syndrome. Am J Clin Pathol 1992, 97 : 523-527
 
6) D'Angelo E, Mozos A, Nakayama SD, et al : Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary. Mod Pathol 2011, 24 : 1360-1367
 
P.265 掲載の参考文献
1) Young RH : Sertoli-Leydig cell tumors of the ovary : review with empasis on historical aspects and unusual variants. Int J Gynecol Pathol 1993, 12 : 141-147
 
2) Kato N, Fukase M, Ono I, et al : Sertoli-Leydig cell tumor of the ovary : immunohistochemical, ultrastructural and genetic study. Hum Pathol 2001, 32 : 796-802
 
3) Zhao C, Vinh TN, McManus K. et al : Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex-cord stromal tumors. Am J Surg Pathol 2009, 33 : 354-366
 
4) Motoyama T, Watanabe H, Gotoh A, et al : Ovarian Sertoli-Leydig cell tumor with elevated serum alpha-fetoprotein. Cancer 1989, 63 : 2047-2053
 
5) Heravi-Moussavi A, Anglesio MS, Cheng SW, et al : Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 2012, 366 : 234-242
 
6) Goulvent T, Ray-Coquard I, Borel S, et al : DICER1 and FOXL2 mutations in ovarian sex-cord stromal tumours : a GINECO Group study. Histpathology 2016, 68 : 279-285
 
P.269 掲載の参考文献
1) Scully RE : Sex cord tumor with annular tubules. A distinctive ovarian tumor of the Peurtz-Jeghers syndrome. Cancer 1970, 25 : 1107-1121
 
2) Tavassoli FA, Norris HJ : Sertoli tumors of the ovary. A clinicopathologic study of 28 cases with ultrastructural observations. Cancer 1980, 46 : 2281-2297
 
3) Hart WR, Kumar N, Crissman JD : Ovarian neoplasms resembling sex cord tumors with annular tubules. Cancer 1980, 45 : 2352-2363
 
4) Young RH, Welch WD, Dickersin GR, et al : Ovarian sex cord tumor with annular tubules : review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 1982, 50 : 1384-1402
 
5) Nomura K, Furusato M, Nikaido T, et al : Ovarian sex cord tumor with anuular tubules. Report of a case. Acta Pathol Jpn 1991, 41 : 701-706
 
6) Deavers MT, Malpica A, Liu J, et al : Ovarian sex cord-stromal tumors : an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol 2003, 16 : 584-590
 
7) Connoly DC, Katabuchi H, Cliby WA, et al : Somatic mutations in the STKll/ LKB1 gene are uncommon n rare gynecological tumor types associated with Peutz Jegher's syndrome. Am J Pathol 2000, 156 : 1139-1148
 
P.273 掲載の参考文献
1) Paraskevas M, Scully RE : Hilus cell tumor of the ovary. A clinicopathological analysis of 12 Reinke crystal-positive and 9 crystal-negative cases. Int J Gynecol Pathol 1989, 8 : 299-310
 
2) Jones MW, Harri R, Dabvbs DJ, et al : Immunohistochemical profile of steroid cell tumor of the ovary : a study of 14 cases and a review of the literature. Int J Gynecol Pathol 2010, 29 : 315-320
 
3) 新井正秀, 上坊敏子, 佐藤倫也他 : Reinke crystalが目立った卵巣間質性ライディク細胞腫の1例. 日臨細胞会誌 1997, 36 : 517-520
 
4) 清川貴子 : 精索間質性腫瘍. 病理と臨床 2015, 33 : 970-976
 
5) Roth LM, Czernobilsky B : Perspectives on pure ovarian stromal neoplasms and tumor-like proliferations of the ovarian stroma. Am J Surg Pathol 2011, 35 : e15-e33
 
6) Juniarto AZ, Setiawati BA, Ediati A, et al : Virilization due to androgen hypersecretion in a patient with ovarian leydig cell tumor : diagnostic and psychosocial implications. Acta Med Indones 2013, 45 : 130-135
 
P.277 掲載の参考文献
1) Hayes MC, Scully RE : Ovarian steroid cell tumors (not otherwise specified) : a clinicopathological analysis of 63 cases. Am J Surg Pathol 1987, 11 : 835-845
PubMed
2) Sasano H, Okamoto M, Mason JI, et al : Immunohistochemical studies of steroidogenic enzymes (aromatase, 17 alpha-hydroxylase and cholesterol side-chain cleavage cytochromes P-450) in sex cord-stromal tumors of the ovary. Hum Pathol 1989, 20 : 452-457
 
3) Mehdi G, Ansari HA, Sherwani RK, et al : Ovarian steroid cell tumour : correlation of histopathology with clinicopathologic features. Patholog Res Int 2011, 2011 : 987895
PubMed
P.282 掲載の参考文献
1) Kurman RJ, Ellenson LH, Ronnett BM : Blaustein's Pathology of the Female Genital Tract. 6th edition. Springer, New York, 2010
 
2) Kurman RJ, Carcangiu ML, Herrington CS, et al : WHO classification of Tumours of Female Reproductive Organs. 4th edition. IARC Press, Lyon, 2014
 
3) Young RH, Scully RE : Ovarian Sertolli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 1985, 9 : 543-569
 
4) Zaloudek C, Norris HJ : Sertolli-Leydig cell tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol 1984, 8 : 405-418
 
5) 大石善丈, 桃崎征也, 蓮尾泰之他 : 紡錘形細胞成分が目立つ卵巣性索間質性腫瘍の一例. 日本婦人科病理学会誌 2014, 5 : 13-16
 
6) Irving JA, Alkushi A, Young RH, et al : Cellular fibromas of the ovary : a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma. Am J Surg Pathol 2006, 30 : 929-938
 
7) Prat J, Scully RE : Cellular fibromas and fibrosarcomas of the ovary : a comparative clinicopathologic analysis of seventeen cases. Cancer 1981, 47 : 2663-2670
 
8) Seidman J : Unclassified Ovarian Gonadal Stromal Tumors : a Clinicopathological Study of 32 Cases. Am J Surg Pathol 1996, 20 : 699-706
 
9) Stewart CJR, Alexiadis M, Crook ML et al : An immunohistochemical and molecular analysisi of problematic and unclassified ovarian sex cord-stromal tumors. Human Pathol 2013, 44 : 2774-2781
 
10) Fattaneh A, Tavassoli FA, Deville P : Pathology and Genetics of Tumours of the Breast and Female Genital Organs. World Health Organization Classification of Tumours. IARC Press, Lyon, 2003
 
11) Shah SP, Kobel M, Senz J, et al : Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 2009, 360 : 2719-2729
 
12) Heravi-Moussavi A, Anglesio MS, Cheng SWG et al : Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 2012, 366 : 234-242
 
P.284 掲載の参考文献
1) Young RH, Perez-Atayde AR, Scully RE : Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein. Am J Surg Pathol 1984, 8 : 709-718
 
P.286 掲載の参考文献
1) Zaloudek C, Garg K : Ovary and Fallopian Tube. In : Silverberg's Principles and Practice of Surgical Pathology and Cytopathology, (Wick MR, LiVolsi VA, Pfeifer JD, et al eds.), 5th edition. Cambridge University Press, 2015, 2724-2820
 
2) McCluggage WG, Kiyokawa T, Staats PN, et al : Sex cord-stromal tumours : pure stromal tumours, Zaloudek CZ, Mooney EE, Staats PN, et al : Sex cord-stromal tumours : pure sex cord tumours, and Mixed sex-cord-stromal tumours. In : WHO Classfication of Tumours of Female Reproductive Organs. (Kurman RJ, Carcangiu ML, Herrington CS, et al eds.), 4th edition. IARC, Lyon, 2014, 44-49, 50-56
 
P.292 掲載の参考文献
1) Smith HO, Berwick M, Verschraegen CF, et al : Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 2006, 107 : 1075-1085
 
2) Giambartolomei C, Mueller CM, Greene MH, et al : A mini-review of familial ovarian germ cell tumors : an additional manifestation of the familial testicular germ cell tumor syndrome. Cancer Epidemiol 2009, 33 : 31-36
 
3) Kraggerud SM, Hoei-Hansen CE, Alagaratnam S, et al : Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts : implications for pathogenesis. Endocr Rev 2013, 34 : 339-376
 
4) Mangili G, Sigismondi C, Gadducci A, et al : Outcome and risk factors for recurrence in malignant ovarian germ cell tumors : a MITO-9 retrospective study. Int J Gynecol Cancer 2011, 21 : 1414-1421
 
5) Chan JK, Tewari KS, Waller S, et al : The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol 2008, 98 : 111-116
 
6) Pectasides D, Pectasides E, Kassanos D : Germ cell tumors of the ovary. Cancer Treat Rev 2008, 34 : 427-441
 
7) Ulbright TM : Germ cell tumors of the gonads : a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 2005, 18 (Suppl) 2 : S61-S79
 
8) Cao D, Guo S, Allan RW, et al : SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 2009, 33 : 894-904
 
9) Cossu-Rocca P, Jones TD, Roth LM, et al : Cytokeratin and CD30 expression in dysgerminoma. Hum Pathol 2006, 37 : 1015-1021
 
10) Al-Agha OM, Huwait HF, Chow C, et al : FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 2011, 35 : 484-494
 
11) Cheng L, Roth LM, Zhang S,et al : KIT gene mutation and amplification in dysgerminoma of the ovary. Cancer 2011, 117 : 2096-2103
 
12) Hersmus R, Stoop H, van de Geijn GJ, et al : Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas. PLoS One 2012, 7 : e43952
PubMed
13) Hoei-Hansen CE, Kraggerud SM, Abeler VM, et al : Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers. Mol Cancer 2007, 6 : 12
PubMed
14) Teilum G : Classification of endodermal sinus tumour (mesoblatoma vitellinum) and so-called "embryonal carcinoma" of the ovary. Acta Pathol Microbiol Scand 1965, 64 : 407-429
 
15) Poulos C, Cheng L, Zhang S, et al : Analysis of ovarian teratomas for isochromosome 12p : evidence supporting a dual histogenetic pathway for teratomatous elements. Mod Pathol 2006, 19 : 766-771
 
P.295 掲載の参考文献
1) Kurman RJ, Carcangiu ML, Herrington CS, et al : WHO Classification of Tumours of Female Reproductive Organs. 4th edition. IARC, Lyon, 2014
 
2) Cao D, Guo S, Allan RW, et al : SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 2009, 33 : 894-904
 
3) Nogales FF, Preda O, Nicolae A : Yolk sac tumours revisited. A review of their many faces and names. Histopathology 2012, 60 : 1023-1033
 
4) 手島伸一 : 卵黄嚢腫瘍 (ヨークサック腫瘍). 病理と臨床 1990, 8 : 1135-1140
 
5) Griscelli F, Feraud O, Oudrhiri N, et al : Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells. Am J Pathol 2012, 180 : 2084-2096
 
P.298 掲載の参考文献
1) Jundle DM, Shahin MS, Sorosky J, et al : Ovarian mixed germ cell tumor with predominance of polyembryoma : a case report with literature review. Int J Gynecol Pathol 2002, 21 : 78-81
 
2) Takeda A, Ishizuka T, Goto T, et al : Polyembryoma of ovary producing alpha-fetoprotein and HCG : immunoperoxidase and electron microscopic study. Cancer 1982, 49 : 1878-1889
 
3) Nakashima N, Murakami S, Fukatsu T, et al : Characteristics of "embryoid body" in human gonadal germ cell tumors. Hum Pathol 1988, 19 : 1144-1154
 
P.301 掲載の参考文献
1) Teilum G : Classification of endodermal sinus tumour (mesoblatoma vitellinum) and so-called "embryonal carcinoma" of the ovary. Acta Pathol Microbiol Scand 1965, 64 : 407-429
 
2) Kurman RJ, Norris, HJ : Embryonal carcinoma of the ovary : a clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis. Cancer 1976, 38 : 2420-2433
 
P.304 掲載の参考文献
1) Hayashi S, Abe Y, Tomita S, et al : Primary non-gestational pure choriocarcinoma arising in the ovary : a case report and literature review. Oncol Lett 2015, 9 : 2109-2111
 
2) Koo HL, Choi J, Kim KR, et al : Pure non-gestational choriocarcinoma of the ovary diagnosed by DNA polymorphism analysis. Pathol Int 2006, 56 : 613-616
 
3) Hirabayashi K, Yasuda M, Osamura RY, et al : Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis. Gynecol Oncol 2006, 102 : 111-117
 
P.308 掲載の参考文献
1) 手島伸一, 下里幸雄, 岸紀代三他 : 胚細胞性腫瘍. 臓器別臨床病理学的特異性. 病理と臨床 1983, 1 : 472-482
 
2) Gershenson DM, Del Junco G, Copeland LJ, et al : Mixed germ cell tumors of the ovary. Obstet Gynecol 1984, 64 : 200-206
 
3) Kurman RJ, Norris HJ : Malignant mixed germ cell tumors of the ovary. A clinical and pathologic analysis of 30 cases. Obstet Gynecol 1976, 48 : 579-589
 
4) Cheng L, Zhang S, Talerman A, et al : Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma. Hum Pathol 2010, 41 : 716-723
 
5) 長坂徹郎 : 胚細胞腫瘍. 病理と臨床 2015, 33 : 977-983
 
P.313 掲載の参考文献
1) Talerman A, Vang R : Teratoma. : Blaustein's Pathology of the Female Genital Tract (Kurman RJ, Ellenson LH, Ronnett BM, eds.), 6th edition. Springer, New York. 2011, 869-891
 
2) 長坂徹郎 : 奇形腫. 腫瘍病理鑑別アトラス 卵巣腫瘍. (本山悌一, 坂本穆彦編). 文光堂, 東京, 2012, 130-142
 
3) 長坂徹郎 : 胚細胞腫瘍. 病理と臨床 2015, 33 : 977-983
 
4) Vang R, Gown AM, Zhao C, et al : Ovarian mucinous tumors associated with mature cystic teratomas : morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol 2007, 31 : 854-869
 
5) McKenny JK, Soslow RA, Longacre TA : Ovarian mature teratomas with mucinous epithelial neoplasms : morphologic heterogeneity and association with pseudomyxoma peritonei. Am J Surg Pathol 2008, 32 : 645-655
 
6) Dalmau J, Gleichman AJ, Hughes E, et al : Anti-NMDA-receptor encephalitis : case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7 : 1091-1098
 
P.317 掲載の参考文献
1) Norris HJ, Zirkin HJ, Benson WL : Immature (malignant) teratoma of the ovary : a clinical and pathologic study of 58 cases. Cancer 1976, 37 : 2359-2372
 
2) O'Connor DM, Norris HJ : The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol 1994, 13 : 283-289
 
3) Robby SJ, Scully RE : Ovarian teratoma with glial implants on the peritoneum. An analysis of 12 cases. Hum Pathol 1970, 1 : 643-653
 
4) Abiko K, Mandai M, Hamanishi J, et al : Oct 4 expression in immature teratoma of the ovary : relevance to histologic grade and degree of differentiation. Am J Surg Pathol 2010, 34 : 1842-1848
 
5) Ferguson AW, Katabuchi H, Ronnett BM, et al : Glial implant in gliomatosis peritonei arise from normal tissue, not from the associated teratoma. Am J Pathol 2001, 159 : 51-55
PubMed
6) Best DH, Butz GM, Moller K, et al : Molecular analysis of an immature ovarian teratoma with gliomatosis peritonei and recurrence suggests genetic independence of multiple tumors. Int J Oncol 2004, 25 : 17-25
PubMed
P.319 掲載の参考文献
1) Ueda G, Yamasaki M, Inoue M, et al : A rare malignant ovarian mixed germ cell tumor containing pancreatic tissue with islet cells. Int J Gynecol Pathol 1984, 3 : 220-231
 
P.320 掲載の参考文献
1) 三浦泰朗, 西東瑠璃, 森正也 : 前立腺組織および前立腺癌を伴った卵巣成熟嚢胞性奇形腫の1例. 診断病理 2014, 31 : 176-178
 
2) Halabi M, Oliva E, Mazal PR, et al : Prostatic tissue in mature cystic teratomas of the ovary : a report of four cases, including one with features of prostatic adenocarcinoma, and cytogenetic studies. Int J Gynecol Pathol 2002, 21 : 261-267
 
P.321 掲載の参考文献
1) Nielsen SN, Scheithauer BW, Gaffey TA : Gliomatosis peritonei. Cancer 1985, 56 : 2499-2503
 
2) Muller AM, Sondgen D, Strunz R, et al : Gliomatosis peritonei : a report of two cases and review of the literature. Eur J Obstet Gynecol Reprod Biol 2002, 100 : 213-222
 
3) Dadmanesh F, Miller DM, Swenerton KD, et al : Gliomatosis peritonei with malignant transformation. Mod Pathol 1997, 10 : 597-601
 
P.324 掲載の参考文献
1) Robboy SJ, Shaco-Levv R, Peng RY, et al : Malignant struma ovarii : an analysis of 88 cases, including 27 with extraovarian spread. Int J Gynecol Pathol 2009, 28 : 405-422
 
2) Dunsendorfer T, deLas Morenas A, Kalir T, et al : Struma ovarii and hyperthyroidism. Thyroid 1999, 9 : 499-502
 
3) Teale E, Gouldesbrough DR, Peacey SR : Grave's disease and coexisting struma ovarii : struma expression of thyrotropin receptors and the presence of thyrotropin receptor stimulating antibodies. Thyroid 2006, 16 : 791-793
 
4) Szyfelbein WM, Young RH, Scully RE : Struma ovarii simulating ovarian tumors of other types. A report of 30 cases. Am J Surg Pathol 1995, 19 : 21-29
 
5) Roth LM, Karseladze AI : Highly differentiated follicular carcinoma arising from struma ovarii : a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis. Int J Gynecol Pathol 2008, 27 : 213-222
 
6) Schmidt J, Derr V, Heinrich MC, et al : BRAF in papillary thyroid carcinoma of ovary (struma ovarii). Am J Suug Pathol 2007, 31 : 1337-1343
 
P.329 掲載の参考文献
1) Robboy SJ, Norris HJ, Scully RE : Insular carcinoid primary in the ovary. A clinicopathologic analysis of 48 cases. Cancer 1975, 36 : 408-418
 
2) Robboy SJ, Scully RE, Norris HJ : Primary trabecular carcinoid of the ovary. Obstet Gynecol 1977, 49 : 202-207
 
3) Robboy SJ, Scully RE : Strumal carcinoid of the ovary : an analysis of 50 cases of a distinct tumor composed of thyroid tissue and carcinoid. Cancer 1980, 46 : 2019-2034
 
4) Motoyama T, Katayama Y, Watanabe H, et al : Functioning ovarian carcinoids induce severe constipiation. Cancer 1992, 70 : 513-518
 
5) 本山悌一 : 卵巣カルチノイドの特性と発生. 日本婦人科病理・コルポ誌 1996,14 : 129-134
 
6) Desouki MM, Lioyd L, Xu H, et al : CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Hum Pathol 2013, 44 : 2536-2541
 
7) Muller KE, Tafe LJ, Gonzalez JZ, et al : Ovarian strumal carcinoid producing peptide YY associated with severe constipation : a case report and review of the literature. Int J Gynecol Pathol 2015, 34 : 30-35
 
P.332 掲載の参考文献
1) Katsube Y, Berg JW, Silverberg SG : Epidemiologic pathology of ovarian tumors : a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area, 1 July-31 December 1969 and 1 July-31 December 1979. Int J Gynecol Pathol 1982, 1 : 3-16
 
2) Zaloudek C, Garg K : Ovary and Fallopian Tube. In : Silverberg's Principles and Practice of Surgical Pathology and Cytopathology (Wick MR, LiVolsi VA, Pfeifer JD, et al eds.), 5 th edition. Cambridge University Press, 2015, 2724-2820
 
3) Prat J, Cao D, Carinelli SG, et al : Germ cell tumours, and Monodermal teratoma and somatic-type tumours arising from a dermoid cyst. In : WHO Classification of Tumours of Female Reproductive Organs (Kurman RJ, Carcangiu ML, Herrington CS, et al, eds.), 4 th edition. IARC, Lyon, 2014, 57-66
 
4) Hackethal A, Brueggmann D, Bohlmann MK, et al : Squamous-cell carcinoma in mature cystic teratoma of the ovary : systematic review and analysis of published data. Lancet Oncol 2008, 9 : 1173-1180
 
P.333 掲載の参考文献
1) Shapiro PF : Metastasis of thyroid tissue to abdominal organs : with special case report of a struma ovarii metastasizing to the omentum. Ann Surg 1930, 92 : 1031-1042
 
2) Karseladze AI, Kulinitch SI : Peritoneal strumosis. Pathol Res Pract 1994, 190 : 1082-1085
 
3) Roth LM, Karseladze AI : Highly differentiated follicular carcinoma arising from struma ovarii : a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis. Int J Gynecol Pathol 2008, 27 : 213-222
 
P.334 掲載の参考文献
1) Kleinman GM, Young RH, Scully RE : Primary neuroectodermal tumors of the ovary : a report of 25 cases. Am J Surg Pathol 1993, 17 : 764-778
 
2) Kawauchi S, Fukuda T, Miyamoto S, et al : Peripheral primitive neuroectodermal tumor of the ovary confirmed by CD99 immunostaining, karyotypic analysis, and RT-PCR for EWS/ FLI-1 chimeric mRNA. Am J Surg Pathol 1998, 22 : 1417-1422
 
3) de Alava E, Gerald WL : Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 2000, 18 : 204-213
 
4) O'sullivan MJ, Perliman EJ, Furman J, et al : Visceral primitive peripheral neuroectodermal tumors : a clinicopathologic and molecular study. Hum Pathol 2001, 32 : 1109-1115
 
P.335 掲載の参考文献
1) Kleinman GM, Young RH, Scully RE : Ependymoma of the ovary : report of three cases. Hum Pathol 1984, 15 : 632-638
 
2) Kleinman GM, Young RH, Scully RE : Primary neuroectodermal tumors of the ovary. Am J Surg Pathol 1993, 17 : 764-778
 
3) Stolnicu S, Furtado A, Sanches A, et al : Ovarian ependymomas of extra-axial type or central immunophenotypes. Hum Pathol 2011, 42 : 403-408
PubMed
4) Komuro Y, Mikami M, Sakaiya N, et al : Tumor imprint cytology of ovarian ependymoma. A case report. Cancer 2001, 92 : 3165-3169
 
P.338 掲載の参考文献
1) Hirakawa T, Tsuneyoshi M, Enjoji M : Squamous cell carcinoma arising in mature cystic teratoma of the ovary : clinicopathologic and topographic analysis. Am J Surg Pathol 1989, 13 : 397-405
 
2) Levine DA, Villella JA, Poynor EA, et al : Gastrointestinal adenocarcinoma arising in a mature cystic teratoma of the ovary. Gynecol Oncol 2004, 94 : 597-599
 
3) Sumi T, Ishiko O, Maeda K, et al : Adenocarcinoma arising from respiratory ciliated epithelium in mature ovarian cystic teratoma. Arch Gynecol Obstet 2002, 267 : 107-109
 
4) Nielsen GP, Young RH, Prat J, et al : Primary angiosarcoma of the ovary : a report of seven cases and review of the literature. Int J Gynecol Pathol 1997, 16 : 378-382
 
P.339 掲載の参考文献
1) Yanai H, Matsuura H, Kawasaki M, et al : Immature teratoma of the ovary with a minor rhabdomyosarcomatous component and fatal rhabdomyosarcomatous metastases : the first case in a child. Int J Gynecol Pathol 2002, 21 : 82-85
 
P.341 掲載の参考文献
1) 小島伊織, 堀部良宗, 今枝義博他 : 卵巣原発悪性黒色腫の1例. 診断病理 2014, 31 : 30-32
 
2) Gupta D, Deavers MT, Silva EG, et al : Malignant melanoma involving the ovary : a clinicopathologic and immunohistochemical study of 23 cases. Am J Surg Pathol 2004, 28 : 771-780
 
3) Cronje HS, Woodruff JD : Primary ovarian malignant melanoma arising in cystic teratoma. Gynecol Oncol 1981, 12 : 379-383
 
P.344 掲載の参考文献
1) Scully RE : Histological Typing of Ovarian Tumours. In : WHO International Histological Classification of Tumours. 2nd edition. Springer, Berlin, 1999
 
2) Scully RE : Gonadoblastoma. A review of 74 cases. Cancer 1970, 25 : 1340-1356
 
3) Zhao S, Kato N, Endoh Y, et al : Ovarian gonadoblastoma with mixed germ cell tumor in a woman with 46, XX karyotype and successful pregnancies. Pathol Int 2000, 50 : 332-335
 
4) Lau YF, Li Y, Kido T : Gonadoblastoma locus and the TSPY gene on the human Y chromosome. Birth Defects Res C Embryo Today 2009, 87 : 114-122
 
5) Cao D, Guo S, Allen RW, et al : SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 2009, 33 : 894-904
 
6) Stoop H, Honecker F, van de Geilin GJ, et al : Stem cell factor as a novel diagnostic marker for early malignant germ cells. J Pathol 2008, 216 : 43-54
 
P.348 掲載の参考文献
1) Young RH, Oliva E, Scully RH : Small cell carcinoma of the ovary, hypercalcemic type : a clinicopathological analysis of 150 cases. Am J Surg Pathol 1994, 18 : 1102-1116
 
2) Eichhorn JH, Young RH, Scully RE : Primary ovarian small cell carcinoma of pulmonary type : a clinicopathologic, immunohistologic, and flow cytometric analysis of 11cases. Am J Surg Pathol 1992, 16 : 926-938
 
3) Rubio A, Schuldt M, Chamorro C, et al : Ovarian small cell carcinoma of pulmonary type arising in mature cystic teratomas with metastases to the contralateral ovary. Int J Surg Pathol 2015, 23 : 388-392
 
4) Foulkes WD, Clarke BA, Hasselblatt M, et al : No small surprise-small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour. J Pathol 2014, 233 : 209-214
 
5) Rabinovich A, Witkowski L, Shaco-Levi R, et al : Primary rhabdoid tumor of the ovary : when large cells become small cells. Gynecol Oncol Rep 2015, 12 : 64-66
 
6) Karanian-Philippe M, Velasco V, Longy M, et al : SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor) : a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas. Am J Surg Pathol 2015, 39 : 1197-1205
 
7) Kurman RJ, Carcangiu ML, Herrinton CS : WHO Classification of Tumours of Female Reproductive Organs. 4th edition. IARC, Lyon, 2014, 69-73
 
8) 永井雄一郎 : その他の腫瘍. 特集 : 卵巣腫瘍 I-病理の新しい考え方. 病理と臨床 2015, 33 : 984-990
 
P.352 掲載の参考文献
1) Kariminejad MH, Scully RE : Female adnexal tumor of probable Wolffian origin. A distinctive pathologic entity. Cancer 1973, 31 : 671-677
 
2) Inoue H, Kikuchi Y, Hori T, et al : An ovarian tumor of probable Wolffian origin with hormonal function. Gynecol Oncol 1995, 59 : 304-308
 
3) Devouassoux-Shisheboran M, Silver SA, Tavassoli FA : Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO) : immunohistochemial evidence in support of a Wolffian origin. Hum Pathol 1999, 30 : 856-863
 
4) Tiltman AJ, Allad U : Female adnexal tumours of probable Wolffian origin : an immunohistochemical study comparing tumours, mesonephric remnants and paramesonephric derivatives. Histopathology 2001, 38 : 237-242
 
5) Nakamura K, Nakayama K, Miura H, et al : Malignant female adnexal tumor of Wolffian origin (FATWO) positive for CD56 : a possible diagnostic role for the biomarker. Eur J Gynaecol Oncol 2014, 5 : 580-583
 
6) Harada O, Ota H, Takagi K, et al : Female adnexal tumor of probable wolffian origin : morphological, immunohistochemial, and ultrastructural study with c-kit gene analysis. Pathol Int 2006, 56 : 95-100
 
P.356 掲載の参考文献
1) Nogales FF, Carvia RE, Donne C, et al : Adenomas of the rete ovarii. Hum Pathol 1997, 28 : 1428-1433
 
2) Rutgers JL, Scully RE : Cysts (cystadenomas) and tumors of the rete ovarii. Int J Gynecol Pathol 1988, 7 : 330-342
 
3) McCluggage WG, Daya D, Ip P, et al : Mesothelial tumours. In : WHO Classification of Tumours of Female Reproductive Organs. (Kurman RJ, Carcangiu ML, Herrington CS. et al. eds.) IARC, Lyon, 2014, 73
 
4) Clement PB : Selected miscellaneous ovarian lesions : small cell carcinomas, mesothelial lesions, mesenchymal and mixed neoplasms, and non-neoplastic lesions. Mod Pathol 2005, 18 (Suppl 2) : S113-S129
 
5) Scully RE, Dickersin GR : Small cell carcinoma of the ovary that is commonly associated with hypercalcemia is a neuroendocrine tumor on the basis of presently available evidence. Int J Gynecol Pathol 1989, 8 : 296-297
 
6) Young RH, Silva EG, Scully RE : Ovarian and juxtaovarian adenomatoid tumors : a morphologic feature present in all adenomatoid tumors : a report of six cases. Int J Gynecol Pathol 1991, 10 : 364-371
 
7) Skinnider B, Young RH : Infarcted adenomatoid tumor : a report of five cases of a facet of a benign neoplasm that may cause diagnostic difficulty. Am J Surg Pathol 2004, 28 : 77-83
 
8) Hirakawa T, Tsuneyoshi M, Enjoji M : Adenomatoid tumor of the ovary : an immunohistochemical and ultrastructural study. Jpn J Clin Oncol 1988, 18 : 159-166
 
9) Phillips V, McCluggage WG, Young RH : Oxyphilic adenomatoid tumor of the ovary : a case report with discussion of the differential diagnosis of ovarian tumors with vacuoles and related spaces. Int J Gynecol Pathol 2007, 26 : 16-20
 
10) Ghossain MA, Chucrallah A, Kanso H, et al : Multilocular adenomatoid tumor of the ovary : ultrasonographic findings. J Clin Ultrasound 2005, 33 : 233-236
PubMed
P.357 掲載の参考文献
1) Ishikura H, Scully RE : Hepatoid carcinoma of the ovary : a newly described tumor. Cancer 1987, 60 : 2775-2784
 
2) Tochigi N, Kishimoto T, Supriatna Y, et al : Hepatoid carcinoma of the ovary : a report of three cases admixed with a common surface epithelial carcinoma. Int J Gynecol Pathol 2003, 22 : 266-271
 
P.360 掲載の参考文献
1) Fox H, Langley FA, Govan AD, et al : Malignant lymphoma presenting as an ovarian tumour : a clinicopathological analysis of 34 cases. Br J Obstet Gynaecol 1988, 95 : 386-390
 
2) Vang R, Medeiros LJ, Warnke RA, et al : Ovarian non-Hodgkin's lymphoma : a clinicopathologic study of eight primary cases. Mod Pathol 2001, 14 : 1093-1099
 
3) Dimopoulos MA, Daliani D, Pugh W, et al : Primary ovarian non-Hodgkin's lymphoma : outcome after treatment with combination chemotherapy. Gynecol Oncol 1997, 64 : 446-450
 
4) Emery JD, Kennedy AW, Tubbs RR, et al : Plasmacytoma of the ovary : a case report and literature review. Gynecol Oncol 1999, 73 : 151-154
 
5) Maguire A, Castriciano G, Walker J, et al : Case study : diffuse large B-cell lymphoma arising in mature cystic teratoma. Int J Gynecol Pathol 2015, 34 : 459-464
 
P.364 掲載の参考文献
1) Pais RC, Kim TH, Ragab AH, et al : Ovarian tumors in relapsing acute lymphoblastic leukemia : a review of 23 cases. J Pediat Surg 1991, 26 : 70-74
 
2) Barcos M, Lane W, Gomez GA, et al : An autopsy study of 1206 acute and chronic leukemias (1958-1982). Cancer 1987, 60 : 827-837
 
3) 佐藤栄一, 蓮井和久 : ATLLの剖検所見, レトロウイルス疾患-ATLとAIDSの全て-. 病理と臨床 (臨増) 1993, 11 : 163-170
 
4) Cunningham I : The clinical behavior of 124 leukemic ovarian tumors : clues for improving the poor prognosis. Leuk Lymphoma 2013, 54 : 1430-1436
 
5) Oliva E, Ferry JA, Young RH, et al : Granulocytic sarcoma of the female genital tract : a clinicopathologic study of 11 cases. Am J Surg Pathol 1997, 21 : 1156-1165
 
6) Scully RE, Young RH, Clement PB : Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. AFIP, Washington, DC. 1996 : 366-367
 
7) Kurman RJ, Ellenson LH, Ronnett BM, et al : Blaustein's Pathology of the Female Genital Tract. 6th edition, Springer, New York, 2011 : 1150-1152
 
8) Stolzel F, Rolling C, Radke J, et al : 18F-FDG-PET/ CT for detection of extramedullary acute myeloid leukemia. Haematologica 2011, 96 : 1552-1556
 
P.365 掲載の参考文献
1) Stewart CJ, Ardakani NM, Doherty DA, et al : An evaluation of the morphologic features of low-grade mucinous neoplasms of the appendix metastatic in the ovary, and comparison with primary ovarian mucinous tumors. Int J Gynecol Pathol 2014, 33 : 1-10
PubMed
2) Ronnett BM, Shmookler BM, Diener-West M, et al : Immunohistochemical supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 1997, 16 : 1-9
 
P.372 掲載の参考文献
1) Vang R, Cheung ANY, Kommoss F, et al : Secondary tumours. In : WHO Classification of Tumours of Female Reproductive Organs (Kurman RJ, Carcangiu ML, Herrington CS, et al. eds.), 4th edition. IARC Press, Lyon. 2014, 83-86
 
2) Lerwill MF, Young RH : Metastatic tumors of the ovary. Blaustein's Pathology of the Female Genital Tract (Kurman RJ, Ellenson LH, Ronnett BM. eds.), 6th edition. Springer Verlag, New York, 2011, 929-997
 
3) 清川貴子 : 転移性卵巣腫瘍. 病理と臨床 2011, 29 : 845-849
 
4) Yamanishi Y, Koshiyama M, Ohnaka M, et al : Pathways of metastases from primary organs to the ovaries. Obstet Gynecol Int 2011, 2011 : 612817
 
5) Krukenberg FE : Fibrosarcoma ovarii mucocellulare (carcinomatodes). Archiv fur Gynakologie 1896, 50 : 287-321
 
6) Kiyokawa T, Young RH, Scully RE : Krukenberg tumor of the ovary. A clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 2006, 30 : 277-299
 
7) 前田大地 : 卵巣. 第2部 腫瘍の鑑別に用いられる抗体. 特集 : 免疫組織化学. 診断と治療選択の指針. (深山正久, 猪狩亨, 大橋健一他編) 病理と臨床 (臨時増刊号) 2014, 32 : 191-200
 
8) Moh M, Krings G, Ates D, et al : SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumours of mucinous or endometrioid type. Am J Surg Pathol 2016, 40 : 419-432
PubMed
P.375 掲載の参考文献
1) Burandt E, Young RH : Pregnancy luteoma : a study of 20 cases on the occasion of the 50th anniversary of its description by Dr. William H. Sternberg, with an emphasis on the common presence of follicle-like spaces and their diagnostic implications. Am J Surg Pathl 2014, 38 : 239-244
 
2) Masarie K, Katz V, Balderston K : Pregnacy luteomas : clinical presentations and management strategies. Obstet Gynecol Surv 2010, 65 : 575-582
 
3) Wadzinski TL, Altowaireb Y, Gupta R, et al : Luteoma of pregnancy associated with nearly complete virilization of genetically female twins. Endocr Pract 2014, 20 : e18-e23
 
P.378 掲載の参考文献
1) Sasano H, Fukunaga M, Rojas M, et al : Hyperthecosis of the ovary. Clinicopathologic study of19cases with immunohistochemical analysis of steroidogenic enzymes. Int J Gynecol Pathol 1989, 8 : 311-320
 
2) Barbieri RL, Ryan KJ : Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome : a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol 1983, 147 : 90-101
 
3) Atmaca M, Seven I, Ucler R, et al : An interesting cause of hyperandrogenemic hirsutism. Case Rep Endocrinol 2014, 98722
 
P.381 掲載の参考文献
1) Kalstone CE, Jaffe RB, Abell MR : Massive edema of the ovary simulating fibroma. Obstet Gynecol 1969, 34 : 564-571
 
2) Veras EF, Crow JH, Robboy SJ : Non-neoplastic and tumor-like conditions of the ovary. In : Pathology of the Female Reproductive Tract (Mutter GL, Prat J, eds.), 3 rd edition. Elsevier, Philadelphia, 2014, 535-563
 
P.386 掲載の参考文献
1) Ehrmann DA : Polycystic ovary syndrome. Review. N Engl J Med 2005, 352 : 1223-1236
 
2) NIH : Final report. NIH Evidence-based Methodology Workshop on Polycystic Ovary Syndrome, December 3-5, 2012. <http://prevention.nih.gov/workshops/2012/pcos/resource.aspx.>
 
3) Conway G, Dewailly D, Diamanti-Kandarakis E, et al ; ESE PCOS Special Interest Group : The polycystic ovary syndrome : a position statement from the European Society of Endocrinology. Eur J Endocrinol 2014, 171 : 1-29.
 
4) Blank SK, Helm KD, McCartney CR, et al : Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci 2008, 1135 : 76-84
 
5) 向井清, 真鍋俊明, 深山正久編 : 外科病理学 第4版. 文光堂, 東京, 2006
 
6) Kurman RJ, Hedrick Ellenson L, Ronnet BM eds. : Blaustein's Pathology of the Female Genital Tract. 6th edition. Springer, New York, 2011
 
7) Welt CK, Duran JM : Genetics of polycystic ovary syndrome. Semin Reprod Med 2014, 32 : 177-182
 
8) Chen ZJ, Zhao H, He L, et al : Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 2011, 43 : 55-59
 
9) Shi Y, Zhao H, Shi Y, et al : Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet 2012, 44 : 1020-1025
 
P.389 掲載の参考文献
1) Alvarado-Cabrero I, Stolnicu S, Kiyokawa T, et al : Carcinoma of the fallopian tube : results of a multi-institutional retrospective analysis of 127 patients with evaluation of staging and prognostic factors. Ann Diagn Pathol 2013, 17 : 159-164
 
2) Medeiros F, Muto MG, Lee Y, et al : The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006, 30 : 230-236
 
3) Stewart CJ, Leung YC, Whitehouse A : Fallopian tube metastases of non-gynaecological origin : a series of 20 cases emphasizing patterns of involvement including intra-epithelial spread. Histopathology 2012, 60 : 106-114
 
4) Visvanathan K, Vang R, Shaw P, et al : Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features : a reproducibility study. Am J Surg Pathol 2011, 35 : 1766-1775
 
P.391 掲載の参考文献
1) Sasano H, Sato S, Yajima A, et al : Adrenal rest tumor of the broad ligament : case report with immunohistochemical study of steroidogenic enzymes. Pathol Int 1997, 47 : 493-496
 
P.392 掲載の参考文献
1) Gerald WL, Miller HK, Battifora H, et al : Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol 1991, 15 : 499-513
 
P.393 掲載の参考文献
1) Zaytsev P, Taxy JB : Pregnancy-associated ectopic decidua. Am J Surg Pathol 1987, 11 : 526-530
 
2) Buttner A, Bassler R, Theele C : Pregnancy-associated ectopic decidua (deciduosis) of greater omentum. An analysis of 60 biopsies with cases of fibrosing deciduosis and leiomyomatosis peritonealis disseminata. Pathol Res Pract 1993, 189 : 352-359
 
3) Malpica A, Deavers MT, Shahab I : Gross deciduosis peritonei obstructing labor : a case report and review of the literature. Int J Gynecol Pathol 2002, 21 : 273-275
 
P.398 掲載の参考文献
1) Attanoos RL, Webb R, Dojcinov SD, et al : Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carinoma of the ovary and peritoneum. Histopathology 2002, 40 : 237-244
 
2) Ordonez G : Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesothelioma and serous carcinomas. Hum Pathol 2005, 36 : 1163-1167
 
3) Malpica A, Sant'Ambrogio S, Deavers MT, et al : Well-differentiated papillary mesothelioma of the female peritoneum : a clinicopathologic study of 26 cases. Am J Surg Pathol 2012, 36 : 117-127
 
4) Clement PB, Young RH, Scully RE : Malignant mesotheliomas presenting as ovarian masses. A report of nine cases, including two primary ovarian mesotheliomas. Am J Surg Pathol 1996, 20 : 1067-1080
 
5) Clement PB : Selected miscellaneous ovarian lesions : small cell carcinomas, mesothelial lesions, mesenchymal and mixed neoplasms, and non-neoplastic lesions. Mod Pathol 2005, 18 (Suppl 2) : 113-129
 
6) Daya D, Cheung A, N.Y, Khunamornpong S, et al : Mesothelial tumours. In : WHO Classification of Tumours of Female Reproductive Organs. (Kurman RJ, Carcangiu ML, Herrington CS, et al. eds.) IARC, Lyon, 2014, 90-91
 
7) Clement PB, Young RH : Florid mesothelial hyperplasia associated with ovarian tumors : a potential source of error in diagnosis and staging. Int J Gynecol Pathol 1993, 12 : 51-58
 
8) Sawh RN, Malpica A, Deavers MT, et al : Benign cystic mesothelioma of the peritoneum : a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status. Hum Pathol 2003, 34 : 369-374
PubMed
9) Comin CE, Saieva C, Messerini L : H-caldesmon, calretinin, estrogen receptor, and Ber-EP4 : a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol 2007, 31 : 1139-1148
 
10) Malpica A, Deavers MT, Lu K, et al : Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 2004, 28 : 496-504
 
11) Kurman RJ, Shih IM : Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer : sifting the paradigm. Hum Pathol 2011, 42 : 918-931
 

書評

最近チェックした商品履歴

Loading...